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Cryptosporidiosis, caused by Cryptosporidium spp. is a gastrointestinal disease which gives 
rise to severe life threatening complications in immunecompromised patients. The disease 
causing parasite has a proficient defense system against xenobiotic compounds and 
substances  that renders the only drug designed to treat the gastroenteritis infection 
inefficient in immune compromised patients. This defense system includes a phase II enzyme 
called Glutathione Transferase (GST) which detoxifies a wide range of oxidant based 
substrates. The overexpression of this protein in multi drug resistant cases and its presence 
in multiple stages of the parasites life cycle highlights the parasites dependence and 
utilization of the GST protein thus making it a suitable therapeutic target. This study was then 
set out to determine characteristic features of Cryptosporidium GSTs in comparison to well 
studied GSTs using molecular biology and bioinformatics tools. A genome wide search was 
performed across multiple protein databases to mine the Cryptosporidium GST.  The 15 
Cryptosporidium spp. found to possess full length proteins were compared amongst 
themselves within the species and against other species using phylogenetic analyses. This led 
to the discovery of three novel classes of Cryptosporidium GST based on amino acid sequence 
identity. The classes were named Gamma, Psi and Vega GSTs. The GSTs varied in amino acid 
length, and secondary structure characteristics determined through homology modeling. In 
comparison to preexisting GSTs, the Psi and Vega class GSTs did not have the typical active 
site Tyr7 found in most cytosolic GST, furthermore the Vega class GST also did not have the 
typical thioredoxin like fold conserved in the N-terminal region of all GSTs. The Gamma class 
GSTs were found to most resemble pre existing GSTs consisting of the typical thioredoxin fold 
and the active site Tyr7 and thus selected for expression and purification studies. pET, pCOLD1 
and pCOLDTF vectors were used to determine a suitable vector to facilitate the expression of 
a soluble gamma class GST in Escherichia coli. pCOLDTF which utilizes cold shock proteins at 
low temperatures and a chaperone called trigger factor assisted in the recombinant 
expression of the gamma class GST resulting in a protein with the monomer size of ~50 kDa, 
which is double that of existing GSTs. This is owed to by the N-terminal and C-terminal 
extensions that the protein possesses. The protein was purified to homogeneity using affinity 
chromatography and size exclusion chromatography. The resulting protein was found to be 
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CHAPTER 1:  
 
LITERATURE REVIEW 
1.1. Global Burden of Diseases 
Cryptosporidiosis is a zoonotic parasitic disease that is considered by the Centres for Disease 
Control and Prevention (CDC) as one of the most prevalent of its kind (Chen et al., 2002). 
Though it is not as salient as diseases of the “Big Three” namely Malaria, HIV/AIDS and 
tuberculosis, cryptosporidiosis is still regarded as one of the top five parasitic zoonoses which 
are a burden globally (Hotez et al., 2007, Hotez et al., 2014). 
Cryptosporidiosis is considered a disease of the bottom billion, which affects the  worlds most 
disadvantaged population (Hotez et al., 2009). However, it has often been neglected and 
overlooked by public health officials, researchers and funders (Bamaiyi and Redhuan, 2017, 
Hotez et al., 2009). The neglect of this disease has allowed for its propagation in rural areas 
and urban slums and is slowly allowing the disease to pose a possible pandemic risk (Feasey 
et al., 2009, King and Bertino, 2008). Furthermore, the zoonotic nature of the disease 
increases the threat it poses, as 60 % of infectious diseases that have been identified since 
1940 have also been zoonotic (Morse et al., 2012). What additionally makes Cryptosporidium 
a great health burden is; (i) Cryptosporidiosis contributing  alarming numbers to the global 
burden of disease with 8.37 million disability adjusted life years  according to 2010 data (Hotez 
et al., 2014, Pisarski, 2019). (ii) The vast global distribution of the Cryptosporidium genus 
(Certad et al., 2017, Pisarski, 2019). (iii) The thick-walled oocysts ease of spread and 
propagation through rainwater run offs, floods and other water bodies (Jagai, 2009, Pisarski, 
2019). (iv) Their evasiveness to water treatment through their advanced defense mechanism 
(Certad et al., 2017, Jagai et al., 2009). Cryptosporidium spp. had joined the neglected diseases 
initiative in 2004 to alleviate this burden. However, the World Health Organization (WHO) has 
been greatly critiqued for not including the parasite in the neglected tropical disease category 
despite the crippling effects it has on child development, pregnancy as well as agricultural 
productivity and the common links the disease has to poverty (Hotez et al., 2014, Pisarski, 
2019, Thompson et al., 2016). 
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1.1.1. Gastroenteritis as a Burden of Disease 
Cryptosporidiosis was initially heavily prevalent in the early 1970’s infecting humans and 
various vertebrates including birds, reptiles, fish and mammals (Bird and Smith, 1980, 
Checkley et al., 2015, O’Donoghue, 1995). The sudden sprouting of infections during that time 
incited surveillance into the cause of this disease, and efforts into rapidly developing 
molecular tools to try treat this disease (Harhay et al., 2010). The inability to treat these 
cryptosporidiosis infections early and the deliberate disregard decades up to now allowed 
cryptosporidiosis to emerge as a life-threatening disease (Harhay et al., 2010, Checkley et al., 
2015). Not particularly in developed countries but in underprivileged areas. Realizing the 
burden of disease brought about by Cryptosporidium spp. and the implications linking it to 
poverty lead to its inclusion in the Neglected Disease Initiative by the WHO (Savioli et al., 
2006). Since then, the disease has been excluded from this list despite the growing evidence 
to its case. This exclusion was received negatively as cryptosporidiosis was stated to be the 
most insidious neglected disease urgently deserving of policy prioritization as a global burden. 
It is believed that this prioritization would aid in cryptosporidiosis intervention being 
recognized as a necessity (Pisarski, 2019). 
Cryptosporidiosis is a gastrointestinal disease which is globally known to be responsible for 
inflammation of the digestive tract caused by parasitic infection (Merriman, 2013). This 
disease primarily infects the small intestines whilst also colonizing the lumen and the 
epithelial surface (Certad et al., 2017, Thompson et al., 2016). The pathogenesis occurs from 
interactions between the parasite byproducts which are serine and cysteine proteinases 
(Flynn and Buret, 2004). The membrane bound proteinases cause caspase 3-dependent killing 
of host cells leading to the breakage of the epithelial barrier as well as host inflammatory and 
immunological responses (Guk et al.,2003, Savioli et al., 2006). A cryptosporidiosis infection 
generally leads to enterocyte apoptosis associated with the disruption of tight junctional 
proteins (Certad et al., 2017). Additionally a Cryptosporidium infection induces the 
proteinases activation of the hosts gastrointestinal Proteinase-activated receptor 1 (PAR-1).  
Though the mechanism of activation is not understood, the implications of this is the 
modulation of apoptosis and the increased enterocyte permeability by PAR-1 (Chin et al., 
2003, Yang et al., 2009). 
3 
 
The mode of Cryptosporidium infection is particularly vast, ranging from person to 
person/animal contact, through feces and through ingestion of contaminated water and food 
(Mead et al., 1999, Ryan et al., 2018). Upon infection, symptom manifestation takes about 2-
14 days and is typically characterized with perfuse watery diarrhea, abdominal cramps, 
vomiting, nausea, and low-grade fever which all vary in severity according to the patients 
immunity (Merriman, 2013). The diarrhea from cryptosporidiosis can be identified by being 
yellow in colour with a soft to liquid consistency accompanied with a strong unfamiliar odour. 
In children however, the symptoms observed are mild to severe diarrhea which leads to 
dehydration, growth retardation, cognitive deficit and possible death (Squire and Ryan, 2017).  
The symptoms of this disease are not life threatening in immunocompetent patients as they 
are self-limiting lasting up to three weeks (Certad et al., 2017, Feasey et al., 2012). In 
immunocompromised patients however, a cryptosporidiosis infection can devastate further 
as it may give way to other unwanted downstream diseases. An example of this is wasting 
syndrome, often observed in AIDS patients (Cama et al., 2007). The loss of epithelial barrier 
function induced by a gastroenteritis infection among other failures causes decreased 
absorptive surfaces, leading to malabsorption accompanied by Crohns disease and irritable 
bowel syndrome (Irvine and Marshall, 2000). Other immunocompromised patients could also 
present with jaundice, bile duct infections and even pancreatic infections (Kotloff et al., 2013). 
Despite the relatively disturbing consequences cryptosporidiosis has on its patients, the 
highest incidences of this disease, is found in children younger than the age of five (Delahoy 
et al., 2018, Kotloff et al., 2013). The prevalence of the disease is considerably high in groups 
of all ages, however the levels found in immunocompromised younger children has been 
striking (Certad et al., 2017). Diarrhea however accounts for 10.5% (Striepen, 2013). A report 
from (Kotloff et al., 2013) undertaken from three sub-Saharan African sites and three south 
Asian sites, showed that Cryptosporidium was the second most prevalent parasite responsible 
for severe diarrhea resulting in cases of morbidity in children between 12-24 months old 
(Khan et al., 2019). It was also discovered that often the children who survived the infection 
beyond 12-23 months suffered reduced cognition, impaired immune responses and growth 
retardation in later years regardless of adequate nutrition after treatment (Delahoy et al., 
2018, Guerrant et al., 1999). These statistics reveal that gastroenteritis by Cryptosporidium is 
endemic in the developing world and urgently needs to be addressed. Currently, of the four 
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diarrheal pathogens that contribute to child morbidity, namely rotavirus, Shigella bacteria, 
enterotoxigenic Escherichia coli and Cryptosporidium, Cryptosporidium is the only one that 
does not have fully effective drug treatment or vaccines developed (Guerrant et al., 1990, 
Walker et al., 2010). Whilst treatments and vaccines are available or being developed for the 
diarrheal disease caused by the before mentioned rotavirus, Shigella bacteria and 
enterotoxigenic Escherichia coli pathogens (Kotloff et al., 2013, Striepen, 2013). 
1.2. Cryptosporidium spp.  
There are multiple ways in which gastroenteritis is caused, however the most common form 
of human infection is vectored by the coccoidal Cryptosporidium spp. These species account 
for more than 90% of gastroenteritis contractions (Rossle and Latif, 2013). Organisms in this 
genus are classified in the phylum Apicomplexa under the class Conoidasida (Certad et al., 
2017). Although classified under this phylum, Cryptosporidium lacks the phylum defining 
plasmid known as apicoplast as well as a mitochondria, crippling the haloparasite (Ryan and 
Hijjawi, 2015). For this reason, Cryptosporidium is heavily dependent on the invasion of the 
host, not only for the completion of its life cycle, but virtually all nutrients for a number of 
their metabolic functions (Certad et al., 2017, Miyamoto and Eckmann, 2015, Thompson et 
al., 2016).   
Of the 31 Cryptosporidium spp, C. parvum and C. hominis are responsible for the highest level 
of clinically relevant infections worldwide (Ryan et al., 2016, Squire and Ryan, 2017). Between 
these two species C. parvum is also known for being zoonotic (Xiao and Feng, 2008). A 
threatening source for human infection is seen to come from animal husbandry through the 
release of large amounts of resistant oocysts in surface water and the environment (Ghoneim 
et al., 2017). This was observed in cases of cryptosporidiosis outbreaks in veterinary students, 
children who attended agricultural fairs and research technicians (Xiao and Feng, 2008).  This 
not only causes a strain on human patients but animals as well.  
1.2.1. Life Cycle 
The life cycle of Cryptosporidium is monoxenous, involving both asexual and sexual 
multiplication (Squire and Ryan, 2017). The Cryptosporidium life cycle is divided into six 
developmental stages which are excystation, merogony, gametogony, fertilization and zygote 
development, formation of environmentally resistant oocyst walls and sporogony (Miyamoto 
and Eckmann, 2015, Rossle and Latif, 2013). The onset of a Cryptosporidium spp. infection is 
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through the ingestion of oocysts. These contain four sporozoites within a tough two layered 
wall which are released into the ilium and mark the beginning of the excystation stage (Rossle 
and Latif, 2013). Once released, the sporozoites infect the tissue on the superficial surface of 
the intestinal epithelium causing the destruction of the epithelial layer (Certad et al., 2017, 
Thompson et al., 2016).  
The sporozoites attach to the luminal surface of the epithelial cells and through merogony 
differentiate asexually into spherical tropozoites producing two different types of meronts 
(Thompson et al., 2005, Miyamoto and Eckmann, 2015). Type I meronts form up to eight 
merozoites which then enter neighboring epithelial cells (Striepen, 2013, Hijjawi et al., 2004). 
These go on to either develop into type II meronts or complete another cycle of type I meronts 
undergoing another round of asexual multiplication as depicted in Figure 1.1. The type II 
meronts differentiate into either microgamonts or macrogamonts initiating sexual 
reproduction (Certad et al., 2017, Squire and Ryan, 2017). The fertilization between these 
gamonts results in the formation of a zygote which develops into oocytes containing four 
sporozoites. The two types of oocytes produced are thin walled oocytes which are excreted 
in faeces and infectious to the new host and thin walled oocytes which then recirculate in the 
intestinal tract causing auto infection (Certad et al., 2017, Miyamoto and Eckmann, 2015). 
Through this process the functioning of the intestinal barrier is disruted, weakening its 
absorption functionality and promoting the secretion of fluids, electrolytes and nutrients 
leading to malnutrition and the obvious watery diarrhea (Ryan and Hijjawi, 2015, Striepen, 
2013). 
Cryptosporidium parvum has proven tricky to treat due to the fact that the parasite has a solid 
defense mechanism in place. Firstly, when the sporozoites differentiate into tropozoites the 
parasite resides within a parasitophorous vacuole protecting the parasite from harsh 
environment of the hosts gastrointestinal tract while also allowing acquisition of nutrients 
from the host cell (Miyamoto and Eckmann, 2015, Ryan and Hijjawi, 2015, Xiao and Feng, 
2008). To achieve this, the parasite rests on the apical end of the enterocyte separated from 
the host cytoplasm by the parasite and host membranes and the feeder organelle. The exact 
transportation of ions and nutrients to the parasite is not fully known. However, the existence 
and localization of ATP-binding cassette transporters suggest the existence of a portal of entry 
(LaGier et al., 2001). Secondly, the host cell membrane completely covers the parasite during 
6 
 
its epithelial growth phase. This makes the efficient use of drugs slightly difficult as they have 
to cross this at that stage of the growth cycle (Hijjawi et al., 2004, Miyamoto and Eckmann, 
2015). Thirdly, the C. parvum oocytes are quite resilient when exposed to changes in the 
environment. They are resistant to chemical disinfection and not affected by chlorine, 
chloramines and chlorine dioxides permitted in drinking water treatments (Thompson et al., 
2005). A potent chemical disinfectant for C. parvum is ozone however it runs the risk of being 
hazardous. The overexposure of ozone gives rise to the formation of high concentrations of 
by-products, some of which could be genotoxic (Certad et al., 2017, Ryan and Hijjawi, 2015).  
                           
Figure 1.1: Life cycle of Cryptosporidium spp. taken from Hijjawi et al (2004).  
The ingestion of thick-walled oocysts give rise to sporozoites, which initiate the infection. 
These invade epithelial cells to form trophozoites (Hijjawi et al., 2004). Growth occurs by 
asexual multiplication, leading to further cycles of infection and growth, or sexual 
multiplication involving gamonts and gametes, and leading to fertilized zygotes. These can 
differentiate into thin-walled oocysts that can initiate further rounds of autoinfection, or to 
thick-walled oocysts that are shed in the feces (Ryan and Hijjawi, 2015). 
Due to the devastating and reoccurring nature of this disease, the treatment for 
cryptosporidiosis is highly necessary. However, the only efficient treatment available against 
this diseases is nitazoxanide (NTZ) (Amadi et al., 2002, Rossle and Latif, 2013). This drug is 
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relatively effective in immunocompetent patients but does not yield the same effects for 
immunocompromised patients (Gargala, 2008). Additionally, NTZ has not yet become 
generally available worldwide (Bamaiyi and Redhuan, 2017). Many alternative avenues are 
continuously being explored to neutralize the parasite. Unfortunately, these efforts have not 
yielded any successful results as yet, as other drugs being synthesized have shown to have 
the same effectiveness as NTZ (Amadi et al., 2002, Gargala, 2008, Sparks et al., 2015). 
1.3. Oxidative Stress - Proteins 
Cryptosporidium manages to evade a variety of internal and external stresses such as UV 
radiation, drugs, free radicals as well as the hosts immune response at various stages of its 
life cycle (Bajszár and Dekonenko, 2010, Certad et al., 2017, Ryan and Hijjawi, 2015). This is 
done similarly to how humans and other mammals use oxidative stress for the destruction of 
many xenobiotics and intracellular parasites (Xu et al., 2005). In parasitic protozoa, the 
antioxidant system is used for the prevention of oxidative stress and protection against 
oxidative killing by the hosts immune effector cells (Kang et al., 2013, Mannervik et al., 1985). 
In doing so, the proteins in this system additionally then serve to aid survival from the threat 
posed by other endogenously produced or xenobiotic compounds. This is achieved by the 
metabolism, detoxification and the expelling of xenobiotic compounds and drugs in a highly 
sophisticated process divided into three major parts (Croom, 2012, Xu et al., 2005).  
The process is initiated by phase I enzymes listed in Table 1.1 which function to make 
compounds more hydrophilic while creating sites to allow phase II conjugation reactions to 
occur (Croom, 2012). This makes the xenobiotic compound a less toxic metabolite which is 
more water soluble (Sheehan et al., 2001). This is followed by the binding of phase III enzymes 
to the conjugated compound transporting them out (Xu et al., 2005). Through genome 
analysis, C. parvum has been revealed to code for a various number of these enzymes such as 
Glutathione Peroxidase (GPX), Glutathione-S-Transferase (GST) and superoxide dismutase. 
The existence of these enzymes better prepares Cryptosporidium for its parasitic life, enabling 
it to continuously stain its host (Miyamoto and Eckmann, 2015).  
The presence of these detoxification enzymes coupled to C. parvum resistance to water 
chlorine disinfection raises C. parvum to be a health concern and a potential water borne 
bioterrorism agent (Khan et al., 2001). This highlights an urgency to control C. parvum. 
Alternative avenues are continuously being explored to neutralize the parasite. Multidrug-
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resistance in Cryptosporidium spp. has been most associated with the overexpression of GST 
compared to the other detoxification enzymes that the parasite possesses (Tsavaris and 
Skopelitis, 2007). It is believed to be important through all stages of the parasite’s life cycle. 
The GST enzyme is also vital in the parasites detoxification pathway and thus considered an 
appropriate molecular drug development target (Mauzy et al., 2012).  
1.3.1. Glutathione Transferase Superfamily 
Glutathione transferases (GST) are a family of multifunction proteins typically serving as 
binding proteins in different detoxification processes and cell metabolism (Frova, 2006). They 
belong to phase II group of enzymes along with GPX and thioredoxin as explained in Table 1.1 
(Sheehan et al., 2001). GST catalyze reactions forming glutathione (GSH, 𝛾-Glu-Cys-Gly) 
conjugates and the reduction of hydroperoxides forming oxidized glutathione’s. These are 
formed through nucleophilic aromatic substitutions, Michael additions to α,β-unsaturated 
ketones and epoxide ring-opening reactions (Dixon and Edwards, 2010, Sheehan et al., 2001). 
Typically, the nonpolar compounds conjugated to GSH have electrophilic centers (carbon, 
nitrogen and sulfur) (Oakley, 2011). This enzyme superfamily is divided into three subfamilies 
based on their cellular locations (Oakley, 2005, Sheehan et al., 2001). This diversity makes the 














Table 1.1: Summary of drug metabolizing enzymes 
Categories Enzymes Reactions Functions Reference 
Phase I Aldo-Keto reductase, 
Carboxylesterases, Cytochrome 
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Phase III Multidrug associated protein, 
Organic anion transporting 












Sheehan et al., 
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The three subfamilies are mitochondrial GSTs, microsomal GSTs (or membrane bound) and 
cytosolic GSTs which are generally soluble (Frova, 2006). Other GSTs exists such as 
fosfomycin-resistance proteins FosA and dehydroascorbate reductases in plants which do not 
share the regular conjugative activities previously mentioned and are thus not classified into 
these subfamilies (Torres-Rivera and Landa, 2008). Within the subfamilies, GSTs are further 
divided into classes according to their amino acid sequence identities, with GSTs within each 
class sharing the same immunological cross-reactivity and specificity towards the electrophilic 
substrate and sensitivity to inhibitors (Sheehan et al., 2001, Salinas and Wong, 1999). 
Mitochondrial GSTs and were thought to be ancestors of cytosolic GSTs until it was proved 
that they instead evolved together and then diverged (Robinson et al., 2004). Microsomal 
GSTs contain four classes I, II, III and IV but are very poorly defined and classified (Knight et 
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al., 2008, Nebert and Vasiliou, 2004). Cytosolic GSTs are the most abundant and very well 
described. The classes are described as ubiquitous and organism specific with their functions 
described in Table 1.2 and Figure 1.2. In addition to these classes, a non-catalytic group of 
GSTs exist called Chloride intracellular channel (CLIC) proteins (Littler et al., 2010, Nebert and 
Vasiliou, 2004). Not much else can be added about these proteins but the fact that they exist 
as biologically active monomers, with poor conjugation activity but rather promotes the 
formation of mixed disulphides with glutathione (Frova, 2006). Although they are soluble, they 
can auto-insert into cellular membranes to form ion channels and undergo structural changes 





Table 1.2: The functions of GST classes in addition to glutathione conjugation 
GST Class Cellular 
localization 
General Information Reference 
Alpha  Cytosol Found in a broad range of species. Involved in the biosynthesis of sex steroids and keto-steroid isomerase activity. Deponte and Becker, 2005 
Beta Cytosol Typically found in bacterial species. Known for conjugating antibiotics, assisting in antibiotic resistance to other organisms. Shehu et al., 2019 
CLIC Cytosol Found in a broad range of species. Enter intracellular membranes and form membrane channels. Board and Menon, 2013 
Delta and 
Epsilon 
Cytosol Typically found in insects. Thought to contribute to detoxication or antioxidative stress during development. Delta GSTs are also involved in 
oogenesis.  
Scian et al., 2015, 
Udomsinprasert et al., 2005 
Kappa Mitochondrial To date, found in primates and mice. Oligomerization of adiponectin. Robinson et al., 2004 
Lambda Cytosol Typically found in plants. Function is not yet known as they have no detectable GSH-conjugating activity. Chronopoulou et al., 2017 
MAPEG Microsomal Found in a broad range of species. Involved in production of leukotrienes and prostaglandin E and are mediators of inflammation.  Akil et al., 2012 
Mu Cytosol Found in a broad range of species. Forms inhibitory complexes with ASK1, another member of the MAP kinase pathway. Torres-Rivera and Landa, 
2008 
Omega Cytosol Found in a broad range of species. Catalyzes reduction and thioltransferase reactions.  Wu and Dong, 2012 
Phi Cytosol Typically found in plants. Inhibits oxidative damage through the removal of endogenous cytotoxic hydroperoxides. Munyampundu et al., 2016 
Pi Cytosol Found in a broad range of species. Regulates JNK and TRAF signaling and catalyzes the S-glutathionylation reactions. Prade et al., 1997 
Sigma Cytosol Found in a broad range of species. Involved in prostaglandin synthesis by isomerization of PGH2 – PGD2. Board and Menon, 2013 
Tau Cytosol Typically found in plants. 
Involved in reactive oxygen species scavenging and improves plant chilling tolerance 
Yang et al., 2016 
Theta Cytosol Found in a broad range of species. Shehu et al., 2019 
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Has dichloromethane dehalogenase activity for the degradation of dichloromethane to obtain energy 
Xi Cytosol Typically found in bacteria, fungi, and archaea. 
Aids in extreme haloalkaphilic conditions. 
Di Matteo et al., 2019 
Zeta Cytosol Found in a broad range of species. Involved in isomerization of maleyacetoacetate to fumaracetoacetate in tyrosine degradation pathway and 
biotransformation of dichloroacetic acid to glyoxylate 
Board et al., 1997 
Symbol: *, Based on in silico prediction. Abbreviations: GSH, Glutathione; ASK1, Apoptosis signal-regulated kinase 1; MAP, Mitogen activated protein; JNK, c-Jun N-Terminal 




Figure 1.2: Phylogenetic tree of various GST classes compiled from different species taken from Snyder and 
Maddison (1997). Arrows at the bottom represent the boundaries of divergence that preserve the traditional 
classes of alpha, pi, mu, sigma, and microsomal GSTs. The star marks the strongly supported GST grouping. 
1.3.2. Glutathione Transferase Structure 
GSTs exist as homodimers or heterodimers. The composition of the dimer interface is 
different for each class with the dimerization process being highly specific occurring only 
between subunits within the same gene class (Torres-Rivera and Landa, 2008).  GSTs do not 
form interclass heterodimers since the variant classes have different subunit interfaces 
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(Sheehan et al., 2001). Generally these dimer interfaces are stabilized by lock and key 
structures where the Met, Tyr or Phe side chain residue of one subunit packs into the 
hydrophobic pocket of the other subunit depicted in Figure 1.3 (Hegazy et al., 2004). In some 
cases, the “key” of one class does not line up with the “lock” of the other class resulting in the 
formation of unstable heterodimers (Board and Menon, 2013). Other stabilizing contacts 
observed between GST monomers are N-capping box which is specific patterns of hydrogen 
bonding and hydrophobic interactions situated in the ends of helices in the N-terminal 
domain (Aurora and Rosee, 1998). 
 
Figure 1.3: Glutathione binding site of homodimeric GST (6GSS) showing the lock and key cavity situated after 
α2 helix taken from Hegazy et al (2006). The active site tyrosine and GSH are shown in sticks.  
Despite the proposed common ancestry, it has been found that sequence identity within 
classes is generally high at around 70% while the sequence identity between classes drops to 
as low as 10% (Sheehan et al., 2001). An example of this is the theta class of GSTs which 
contains a broad group of GST-like enzymes such as dehalogenases which results in low intra-
class sequence identity (Rossjohn et al., 1997). In spite of the broad sequence identity their 
crystal structures still show a similar structural fold of the proteins, with differences observed 
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at the active site and the inter-subunit interface. The proteins in this family still have 
monomer sizes of 21-28 kDa averaging an amino acid sequence of ~ 220 (Frova, 2006, Torres-
Rivera and Landa, 2008). 
1.3.3. Conserved Thioredoxin like Fold 
The GST monomers are divided into two domains namely an N-terminal domain and a C-
terminal domain (Oakley, 2005). The N-terminal domain is responsible for GSH binding 
(Torres-Rivera and Landa, 2008, Sheehan et al., 2001). This domain assumes a topology 
resembling a thioredoxin fold which is generally conserved across all GST classes (Board and 
Menon, 2013, Sheehan et al., 2001). This conserved canonical fold is observed in several 
proteins despite the limited sequence identity (Oakley, 2011). The thioredoxin like fold is 
composed of three α helices flanking four β sheets as depicted in Figure 1.4 (Sheehan et al., 
2001). The distinct N-terminal motif has a βαβ and ββα arrangement, which is linked by an α-
helix (Atkinson and Babbitt, 2009). The N-terminus begins with a β1 sheet followed by an α1 
helix leading to a second β2 sheet parallel to β1. An irregular loop region, known as the cis-Pro 
loop connects α2 helix to β3 (Sheehan et al., 2001). The ββα arrangement begins with two β 
sheets (β3 and β4) antiparallel to one another followed by an α3 (Board and Menon, 2013). All 
four β sheets are in the same plane with α1 and α3 oriented below this plane and α2 above it 
generally facing the solvent.  A characteristic proline residue within the loop, connecting α2 
and β3 is found in the least dominant cis conformation and is highly conserved in all GSTs 
(Atkinson and Babbitt, 2009, Wu and Dong, 2012). This cis-pro loop which is not involved in 
any catalysis is incredibly crucial for retaining the enzyme in a catalytically competent 
structure (Atkinson and Babbitt, 2009). The N-terminal domain is responsible for most of the 
glutathione binding site while also being connected to the second domain by a short linker 





Figure 1.4: Schematic diagram representing the thioredoxin fold. The template structure to which the GST N-
terminal domain follows. 
 
The C-terminal domain is positioned downstream the thioredoxin like domain and is 
connected by a short liker sequence (Sheehan et al., 2001). The C-terminal domain is 
composed exclusively of α helices. This domain binds the hydrophobic substrate (Atkinson 
and Babbitt, 2009, Wu and Dong, 2012). Depending on the class of transferases, the C-
termianl domain can be made up of 4 to 8 α helices (Oakley, 2011, Sheehan et al., 2001). This 
end terminal is less conserved across all GST classes at a sequence and structural level with 
the helices varying in number, length, curvature and orientation (Nebert and Vasiliou, 2004, 
Sheehan et al., 2001, Strange et al., 2000). The amino acids of this domain largely contribute 
the residues that bind with the hydrophobic substrate in addition to providing an aspartic acid 
residue which is highly conserved, to the site where the tripeptide glutathione binds (Salinas 
and Wong, 1999). The variation in this region is said to account for the diverse range of 
substrates that are bound to be detoxified. For example the mu class of GST catalyse the 
detoxification of molecules containing oxiranes and α, β unsaturated carbonyl groups due to 
the variable C-terminal components while the alpha class GSTs act on 4-hydroxyalkenals and 
peroxides (Fritz-Wolf et al., 2003).    
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Figure 1.5: Homodimer of Onchocerca volvulus GST 1 showing secondary structure elements.  Alpha helices 
are shown in blue and red, the beta sheets shown in green and the loops shown in pink taken from Perband et 
al (2008).  
 
1.3.4. Active Site 
GST subunits contain two ligand binding sites. These sites are named the glutathione binding 
site (G site) and the hydrophobic substrate binding site (H site) (Sheehan et al., 2001). The G 
site is highly conserved and is an essential feature of the enzymes catalytic mechanism (Dixon 
and Edwards, 2010, Sheehan et al., 2001). The H site is constructed of residues with non-polar 
site chains lying in the C-terminal domain (Mannervik et al., 1988). The two sites together 
constitute the catalytically active site which works autonomously to the other (Frova, 2006).   
1.3.4.1. Glutathione Binding Site 
The G site exclusively binds to tripeptide GSH and is thus highly conserved across the GST 
superfamily (Frova 2006). At the G site, the sulfur of GSH is activated for nucleophilic attack 
(Sheehan et al., 2001). The GSH, which runs antiparallel to the loop found after β3 is bound in 
an extended conformation (Rossjohn et al., 1997). Here electrostatic interactions anchor the 
tripeptide to the domain typically through a network of hydrogen bonds running from β3- β4-
α2 (Oakley, 2011).  GSH is bound and activated using specific residues of amino acids 
depending on the class of GST (Mannervik et al., 1988). The variation of residues responsible 
for GSH activation highlights the chemistry of reactions catalyzed by each isoenzyme (Frova, 
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2006). The amino acids that allow for conjugation or thiol transfer to occur are tyrosine (mu, 
pi, alpha, and sigma classes), serine (theta, zeta classes) or cysteine (omega, beta, lambda and 
CLIC class GSTs) (Prade et al., 1997,Torres-Rivera and Landa, 2008). The tyrosine and serine 
hydroxyl group acts as a hydrogen donors to the GSH thiol group. This leads to the formation 
and stabilization of a highly reactive thiolate anion, which is the target for nucleophilic attack 
of an electrophilic substrate (Frova, 2006). The cysteine however, promotes the formation of 
mixed disulfides GSH instead of forming thiolate anion. The contrast in these mechanisms 
results in the latter of the GST classes having poor GSH conjugation activities, but rather 
promoting redox reactions instead (Board and Menon, 2013).  
1.3.4.2. Hydrophobic Substrate Binding Site 
Positioned adjacent to the G site is the hydrophobic co-substrate binding site denoted the H 
site (Dixon and Edwards, 2010). The H site is mainly formed by residues from the C-terminal 
region and  varies between classes in amino acid sequence and topology allowing for 
numerous substrate specificities (Oakley, 2005). Once GSH has bound to GST, the thiolate 
anion of the GSH is then stabilized enough to conjugate a wide range of electrophiles of 
different physicochemical properties, such as hydrophobicity, shape, and size (Board and 
Menon, 2013). The substrates bound in this site are typically held by residues within the H 
site through hydrophobic interactions.  
1.3.5. Comparison Between Human and Parasitic Active Site  
Analyzing GST structures belonging to parasites or rather species belonging to the 
apicomplexan phylum might give a closer estimation of what the Cryptosporidium spp. GST 
structures might resemble. Much like all other GST structures, parasitic GSTs are also 
enzymically active as homodimers (Hiller et al., 2006). Though packed differently, they too 
follow a thioredoxin like fold. Some GSTs such as Plasmodium falciparum GST (PfGST) have a 
connecting loop between β2 and α2 (Fritz-Wolf et al., 2003). Each of these dimers are held 
together not only by hydrophobic forces but by four salt bridges and another four hydrogen 
bonded amino acid pairs (Fritz-Wolf et al., 2003, Hiller et al., 2006).  
Focusing more into the G site region of the active site, it seems as though apicomplexa models 
share similar binding models to the well-known mu, pi and alpha classes of GST (Prade et al., 
1997, Torres-Rivera and Landa, 2008). However, in PfGST the GSH runs antiparallel to the 
conserved α2-β3 loop, adopting an extended conformation. In PfGST models the G site is also 
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occupied by two formate molecules (Hiller et al., 2006). The formate molecules mimic the 
glutamyl carboxylate of GSH. These two formate molecules are stabilized by the before 
mentioned salt bridges. They are located in a position in the active center corresponding to 
the γ-carbonyl of GSH when compared to the µ, α, and  π classes further illustrating the 
utilization of salt bridges by PfGST. Additionally, in all classes, including PfGST, the active site 
Tyr forms hydrogen bonds to the backbone N of Lys (Fritz-Wolf et al., 2003). At that position, 
only α class GST enzymes possess an Arg that stabilizes the Cys moiety of GSH with the help 
of the active site Try all using the Ne atom.   
The H site is expected to be more variable than the G site to allow for diverse substrate 
binding (Torres-Rivera and Landa, 2008). In most GSTs, the loop joining β1 and α1, together 
with the C-terminal part of the helix α4 and the residues after α8 are what form the H site as 
illustrated in Figure 1.6 (Hiller et al., 2006). The H site is generally shielded by the C-terminal 
region from the surrounding solvent in various ways depending on the class (Frova, 2006). 
The α class uses its large α-9 present at the C-terminus while µ and  π classes posses wall like 
structures. The µ class has an additional ~ 10 residues located between β2 and α1 called the µ 
loop which is also said to assist in reducing solvent accessibility (Board and Menon, 2013, 
Mannervik et al., 2005). PfGST also has a µ loop but it is too short containing only five amino 
acids and thus cannot to form a wall, making the H site of PfGST more solvent accessible 
(Torres-Rivera and Landa, 2008). This suggests that the H site of PfGST allows for the binding 
of a broader range of substrates which include amphiphilic compounds as well (Sheehan et 






Figure 1.6:  Structural comparison of GST enzymes. The mu class enzyme contains the GSH conjugate 1-hydroxy-
2-S-glutathionyl-3-para-nitrophenoxy-propane. The alpha and pi class enzymes are shown in complex with the 
GSH conjugate of EA. In PfGST, the active-site region contains the connecting loop between α-4 and α-5 of the 
crystallographically independent monomer. All structures visualized using pymol. 
 
1.4. GST Catalyzed Reaction 
Although there is a generalized idea of the role of GST in Cryptosporidium, the extent at which 
it is dependent on its GST to avoid inactivation by endogenous and exogenous toxic 
compounds has not been well understood. For this reason, the biochemical mechanism 
cannot accurately be speculated without the structure of the enzyme, size and class of the 
enzyme being known. It is understood however that most xenobiotic compounds are 
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activated by cytochrome P450 resulting in the production of reactive metabolites which 
attack DNA and proteins, thus modifying them (Torres-Rivera and Landa, 2008). GSTs 
primarily function to catalyze reduced GSH conjugation of these toxic electrophilic 
compounds making them more soluble and easily expelled (Frova, 2006, Oakley, 2011). 
Glutathione conjugation reactions are the first step to the mercapturic acid pathway rated as 
an essential detoxification process producing the N-acetylcysteine derivative of its original 
xenobiotic substrate (Pickett and Lu, 1989, Sheehan et al., 2001, Wilce and Parker, 1994). The 
second step of this process is catalyzed by 𝛾-glutamyltransferase. In addition to conjugation 
catalysis, some forms of this enzyme exhibit isomerase activity toward ketosteroids, 
glutathione peroxidase activity toward hydroperoxides from lipids and nucleic acids and they 
also act as carrier proteins (Atkinson and Babbitt, 2009, Sheehan et al., 2001). 
Most GSTs exhibit conjugation activity toward 1-chloro-2, 4-dinitrobenzene (CDNB) and is 
used as a substrate for enzyme assays (Torres-Rivera and Landa, 2008). When conjugating 
CDNB most classes of GST unfold via a highly co-operative two-state pathway (Sheehan et al., 
2001). Initially GST is activated at the G site where a GS anion is formed through the lowering 
of the G-site pKa allowing the deprotonation of the thiol group of cysteine in GSH (Wilce and 
Parker, 1994). This is accomplished by a range of amino acids either tyrosine, serine or 
cysteine governed by the class of GST. The deprotonation to the amino acids hydroxyl group 
lowers the pKa from 9.2 all the way down to 6.2 allowing the formation and stabilization of a 
nucleophilic thiolate anion of GSH facilitating the reaction depicted in Figure 1.7 (Atkins et al., 
1993, Board and Menon, 2013). The Tyr and Ser hydroxyls are not the only components to 
stabilize the GSH thiolate as other studies have shown that the glutamyl  α-carboxyl group of 
GSH may accept the thiol proton for stabilization purposes (Dourado et al 2008, Gustafsson 
et al., 2001). Additionally, when a Cys is used there is a formation of mixed disulphides with 
GSH due to the thiol transferase. Nucleophilic addition can then occur at the H site where the 
nucleophilic GS anion reacts with an aromatic electrophilic substrate (Tsuchida, 2000). The 
resulting substrate is more soluble prompting degradation of the product and excretion as 





Figure 1.7: GSH conjugation to xenobiotic- and GST-catalysed reaction 
It has been hypothesised that the GST catalysed reaction passes through a transition state 
which is an analogue of a Meisenheimer complex as seen in typical nucleophilic addition 
reactions (Prade et al., 1997). Kinetic studies have shown however that the formation of this 
transition step is the rate limiting step of GST catalysis (Prade et al., 1997).  
In addition to the catalytic role that GSTs play in the conjugation and elimination of 
electrophilic compounds, these proteins have also been implicated in a range of alternative 
functions. In some cases, GSTs have been found to have the same catalytic activity as 
maleylacetoacetate isomerases. These enzymes catalyse the isomerization of 
maleylacetoacetate to fumarylacetoacetate which is an essential step in the tyrosine and 
phenylalanine degradation pathway (Gilge et al., 2008, Townsend et al., 2009). Other GSTs 
such as alpha class GSTs exhibit keto-steroid isomerase activity and glutathione peroxidase 
activity in addition to the wide range of glutathione conjugation reactions they catalyse 
(Benson et al., 1977). GSTs also play a considerable role in the regulation of cell signalling 
pathways (Board and Menon 2013). Pi class GSTs are powerful inhibitors of signalling 
molecules such as Jun Kinase, ASK1 and TRAF2 done so by conjugation independent protein-
protein interactions (Adler et al., 1999, Elsby et al., 2003, Townsend et al., 2009). Other GSTs 
fall under the GST superfamily, but do not observe any significant enzymatic activity such as 
the CLIC proteins previously discussed in section 1.4.1. Another group of GSTs have also been 
recorded to being involved in the glutathionylation of protein cysteinyl thiols (Alder et al., 
1999, Castro-Caldas et al., 2012). When these thiol groups are exposed on the surfaces of 
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proteins, they become susceptible to oxidative damage, thus being reversibly oxidized to 
sulfenic and sulfinic acid, targeting the protein for proteosomal degradation upon exposure 
to more stress (Cooper et al., 2011, Dalle-Donne et al., 2007).  Glutathionylation, which is the 
formation of reversible disulphide bonds between protein thiols and glutathione, is 
considered a primary line of defence against oxidative stress (Cooper et al., 2011, Lock et al., 
2011). As different GSTs emerge with varying structural motifs, sequence compositions and 
physiological properties, more functions of these enzymes emerge and are constantly being 
discovered, with GSTs no longer being limited to just electrophile conjugation alone.  
1.5. GST Application 
It is very apparent that GSTs bare vital significance in many parasites for detoxification 
purposes due to the lack of cytochrome P450 activity (Tsuchida, 2000). This statement is also 
supported by knockout studies in P. falciparum which showed the importance of  functional 
GSTs in these organisms (Deponte and Becker, 2005). Additionally, GSTs and other phase II 
enzymes have been found to inhibit carcinogenesis as well as tumorigenesis through their 
detoxification activities in many studies (Devadoss et al., 2018, Sheehan et al., 2001, Zheng et 
al., 1992). These facts place them as targets for the development of vaccines or 
chemotherapeutic agents.  
The biological functions that GSTs play in various roles are crucial and have a huge following 
in biomedical, biotechnological and nanotechnological sectors as displayed in Table 1.3. The 
biotechnological techniques already laid out have greatly increased our knowledge of 3D 
structures, functions and the evolutionary roles of the enzyme. This knowledge base can be 
used for the bioengineering and transgenesis of novel biomolecules of medical and industrial 
importance through forced evolution (Frova, 2006). The proteins are considered highly 








Table 1.3: Various glutathione transferase applications  
Application Description Reference 
Biosensor In GSTs from maize fiber-optic portable biosensor were 
constructed to identify  a pesticide-like atrazine.  
 
Andreou and Clonis, 2002 
GSTs from soy were used to construct biosensor for the 
identify chloroacetanilide herbicide alachor. 
 
Fragoulaki et al., 2007 
Optical biosensors which are sensitive for the detection 
of carcinogen captan in water supplies constructed from 
GST immobilized gel fillm.  
 
Choi et al., 2003 
Bioassay Mosquito GSTs were used to construct specific enzyme 
assay for the determination of DDT. 
Morou et al., 2008 
Biomarker Pi class GSTs were used to generate immunohistological 
markers for gastric cancer and gliomas. 
Fan et al., 1995 
Drug and Pro-drug 
Design 
Alpha class GSTs were used for the production of drugs 
to treat steroid hormone dependent diseases such as 
cancer. 
Johansson and Mannervik, 
2001 
Pi class GSTs are used for Pro-drug activation such as the 
actiation of Telcyta. 
Morgan et al., 1996 
Bioremediation Phi and Tau class GSTs from plats were used for the 
detoxification of herbicides such as chloroacetanilide, 
thiocarbamate and aryloxyphenoxypropionate. 
Axarli et al., 2009 
Transgenesis GST genes from maize were used to transgenicially 
engineer tobacco with high tolerance to the herbicide 
alachlor. 
Karavangeli et al., 2005 
 
There is no doubt that the existence and contribution of GSTs to the metabolism and 
neutralization of drugs and other xenobiotics is an otherwise advantageous system in plants, 
animals and humans. It is however catastrophic when utilized by disease causing bacteria and 
parasites (Torres-Rivera and Landa, 2008). Not only do they cause the accumulation of 
multidrug resistant strains of bacteria but they are also responsible for chemotherapy 
resistance within some tumour cells (Oakley, 2005, Sheehan et al., 2001). For this reason, the 
urgency to develop inhibitors to enhance the therapeutic efficiency of Nitazoxanide or 
terminate cryptosporidiosis all together has never been more imperative.  
Before inhibitors can be designed, the exact mechanism taken by the Cryptosporidium’s GST 
needs to be understood together with its biophysical characteristics. It is unfortunate 
however that there is a great deal unknown about the Cryptosporidium GSTs. Various studies 
would be needed to determine the GST classification,  three-dimensional (3D) structure of 
the enzyme, general size, and oligomerization patterns of the protein. Through structure 
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determination, ligand-protein interactions can be maximised to design a chemical test suited 
to inhibit the enzyme. 
Hindering the enzymes defence mechanism against the host and environmental reactive 
species could be the best possible option in reducing the catastrophic effects that have 
unfolded due to Cryptosporidium infections in immune-compromised patients. In an 
experiment conducted by Fritz-Wolf et al (2003). The isolation and characterisation of PfGST 
which was present in all intra-erythrocyte stages of the parasite was sought. The crystal 
structure of the GST was determined so to design an inhibitor to reduce number of resistant 
parasites against the presently available drugs (Hiller et al., 2006). Plasmodium falciparum 
GST could not be assigned to any pre-existing class of GST indicating an ever growing class of 
GSTs (Deponte and Becker, 2005). The same mode of action can be taken for the 
determination of Cryptosporidium spp. GST so to determine the structure of the protein for 
possible drug design.  
1.6. Aim of Study 
Currently very little is known about the molecular and biophysical properties of 
Cryptosporidium GST. To this end the aim of this study was to use bioinformatic and molecular 
biology tools to fill this knowledge gap through elucidating a 3D structure of the parasitic 
protein for a comparative analysis with well studied GSTs. The secondary aim was to obtain a 
pure recombinant GST protein expressed using an appropriate expression vector to lead way 
for further characterization steps.  
To achieve these aims the following objectives were set out: 
• Genome data mining of all Cryptosporidium GSTs 
• Phylogenetic analysis and identification of Cryptosporidium GST classes 
• Homology modelling of Cryptosporidium GST  
• Recombinant expression of soluble Cryptosporidium GST  
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2.1.  Abstract  
Cryptosporidiosis, caused by protozoan parasites of the genus Cryptosporidium, is estimated 
to rank as a leading cause in the global burden of neglected zoonotic parasitic diseases. This 
diarrheal disease is the second leading cause of death in children under 5 years of age. Based 
on the C. parvum transcriptome data, glutathione transferase (GST) has been suggested as a 
drug target against this pathogen. GSTs are diverse multifunctional proteins involved in 
cellular defense and detoxification in organisms and help pathogens to alleviate chemical and 
environmental stress. In this study, we performed genome-wide data mining, identification, 
classification and in silico structural analysis of GSTs in fifteen Cryptosporidium species. The 
study revealed the presence three GSTs in each of the Cryptosporidium species analyzed in 
the study. Based on the percentage identity and comprehensive comparative phylogenetic 
analysis, we assigned Cryptosporidium species GSTs to three new GST classes, named Vega 
(ϑ), Gamma (γ) and Psi (ψ). The study also revealed an atypical thioredoxin-like fold in the C. 
parvum GST1 of the Vega class, whereas C. parvum GST2 of the Gamma class and C. melagridis 
GST3 of the Psi class has a typical thioredoxin-like fold in the N-terminal region. This study 














Cryptosporidiosis is a zoonotic parasitic disease that is caused by Cryptosporidium spp. (Savioli 
et al., 2006, Pisarski, 2019, Pumipuntu and Piratae, 2018). This disease is estimated to be 
among the highest ranking causes in the global burdens of zoonotic parasitic disease, with an 
estimate of 8.37 million disability-adjusted life years (Hotez et al., 2014, Pisarski, 2019). 
Recently, large population studies revealed that cryptosporidiosis has become a fast-growing 
burden to children under the age of five years (Kotloff et al., 2013, Sow et al., 2016). 
Moreover, the Global Enteric Multicenter Study  showed that Cryptosporidium is significantly 
associated with diarrheal disease among children <24 months of age in sub-Saharan Africa 
and South Asia (Sow et al., 2016). Similar studies also found Cryptosporidium to be the second 
leading cause of moderate to severe diarrhea in infants after Rotavirus (Kotloff et al., 2013). 
It is interesting to note that vaccines/treatment are already available or fast being developed 
for three of four diarrheal pathogens (Rotavirus, Shigella and heat-stable, enterotoxigenic 
Escherichia coli), the exception being Cryptosporidium, highlighting the need to address this 
disease (Striepen, 2013). Despite the global burden of cryptosporidiosis, to date nitazoxanide 
(NTZ) is the only treatment available for this disease. NTZ only appears to be effective in 
patients with a good immune response, whilst having limited efficacy in malnourished 
children and ineffective in immunocompromised people (Amadi et al., 2009, Bhalchandra et 
al., 2018, Cabada and White Jr, 2010).  The lack of effective treatment for cryptosporidiosis, 
coupled with the fact that it is now considered the most common cause of human parasitic 
diarrhea in the world, highlights the need for more research on Cryptosporidium to identify 
new drug targets and thus develop new drugs (Widmer et al., 2020).  
Cryptosporidiosis is typically characterized by nausea, profuse watery diarrhea, abdominal 
cramps, vomiting and low-grade fever, which manifest after 14 days and last up to 2.5 months 
in immune-competent patients (Certad et al., 2017, Leitch and He, 2011). These symptoms 
are usually self-limiting in immune-competent patients; however, in immunocompromised 
hosts they can be devastating, with the disease manifesting as life-threatening and often 
becoming extraintestinal (Leitch and He, 2011). The gastrointestinal infection can spread to 
other sites, such as the gall bladder, biliary tract, pancreas and pulmonary system. 
Cryptosporidiosis can be contracted through the fecal-oral route, through contact with 
infected animals or humans or contaminated food or water (Leitch and He, 2011).  
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Of the Cryptosporidium species that exist, C. hominis and C. parvum are responsible for the 
highest level of clinically relevant infections worldwide (Pumipuntu and Piratae, 2018). The 
remaining species have mild zoonotic properties causing moderate-to-severe diarrhea in 
humans (Pumipuntu and Piratae, 2018). Cryptosporidium species are reported to have an 
efficient defense mechanism that allows it to cope with a wide range of environmental 
stresses such as changes in temperature, drugs, free radicals, as well as the host’s immune 
responses at various life stages (Certad et al., 2017). Genome analysis of C. parvum revealed 
that it contains various defense proteins such as glutathione transferase (GST), glutathione 
peroxidase and superoxide dismutase, which are known for detoxification, signal modulation 
and aromatic amino acid catabolism (Abrahamsen et al., 2004). The existence of these 
enzymes may provide C. parvum with the abilities to maintain its parasitic lifecycle, enabling 
it to survive and persist in its host.  
Among the above-mentioned enzymes, GST is found to be expressed in all stages of the C. 
parvum parasite’s life cycle (Mauzy et al., 2012), thus making it a promising therapeutic target 
(Khoza et al., 2018). GSTs have been studied as drug targets against infectious agents and 
metabolic disorders (Harwaldt et al., 2002, Pljesa-Ercegovac et al., 2018, Rao et al., 2000). 
GSTs are a diverse group of multifunctional proteins that are distributed ubiquitously in 
eukaryotes and prokaryotes (Allocati et al., 2012, Sheehan et al., 2001). These enzymes play 
an important role in cellular defense and detoxification (Frova, 2006, Sheehan et al., 2001, 
Wilce and Parker, 1994). They catalyze the nucleophilic conjugation of the reduced tripeptide 
glutathione (GSH) thiol group to the electrophilic substrates to convert them to less harmful, 
more soluble compounds. Based on the location, the GST superfamily is divided into three 
sub-families namely, soluble or cytosolic GSTs, mitochondrial GSTs and membrane-associated 
proteins involved in eicosanoid and gluthatione metabolism (MAPEG) with the cytosolic GSTs 
being the most characterized (Table S1). The GSTs are generally divided into classes based on 
amino acid sequence similarity, with GSTs within each class sharing similar immunological 
cross-reactivity and specificity towards the electrophilic substrate and sensitivity to inhibitors 
(Glisic et al., 2015, Salinas and Wong, 1999, Sheehan et al., 2001). GSTs within each class 
typically share as little as 60% amino acid sequence identity however, some classes can share 
from as little as 40% (Allocati et al., 2009, Frova, 2006, Oakley, 2011, Sheehan et al., 2001, 
Soranzo et al., 2004). It is generally accepted that the assignment of different GSTs to specific 
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classes must fall within these limits, with sequences sharing less than 25-30% designated to 
their own class (Allocati et al., 2009, Frova, 2006, Oakley, 2011, Sheehan et al., 2001, Soranzo 
et al., 2004). Information on different GST classes found in organisms, their cellular 
localization and functions are listed in Table S1.  
Typical GSTs are dimeric in structure and each monomer is divided into two domains (Frova, 
2006, Sheehan et al., 2001). The N-terminal domain of conical GSTs assumes a topology 
resembling the thioredoxin fold with a βαβ-ββα motif. This domain also houses an important 
conserved region of the active site where a catalytically active Tyr, Ser or Cys is found to 
interact with the GSH thiol group. The C-terminal domain of typical GSTs is all helical and 
connected by a short linker sequence called the cis-Pro loop with a highly-conserved proline 
residue in cis conformation (Frova, 2006). The active site is comprised of the glutathione 
binding site (G-site) and the hydrophobic substrate binding site (H-site), located in the N- 
terminal and C–terminal domain respectively. The G-site exclusively binds glutathione and is 
highly conserved, whilst the H-site accepts more variability so to accommodate an extensive 
range of toxic electrophilic substances (Frova, 2006, Sheehan et al., 2001). 
Despite the importance of GSTs, especially as potential drug targets against Cryptosporidium 
(Khoza et al., 2018), to the best of our knowledge, no literature is available to date on 
Cryptosporidium GSTs with regards to their distribution, the GST classes and structural 
information. Thus, this study is aimed at addressing this research gap. In this study, genome 
data mining, identification, phylogenetic and structural analysis of GSTs in fifteen 
Cryptosporidium species was carried out.  
2.3. Methods  
2.3.1. Species and Database 
Cryptosporidium species genomes that are available for public use at the Cryptosporidium 
database or CryptoDB (Heiges et al., 2006) (https://cryptodb.org/cryptodb/app; release 48 
beta, 27 August 2020; accessed on 14 September 2020) and at National Center for 
Biotechnology information (NCBI) (Agarwala et al., 2018) 
(https://www.ncbi.nlm.nih.gov/datasets/genomes/?txid=5806; accessed on 14 September 
2020) were used in the study. The Cryptosporidium pathogens examined in this study include 
ones from both humans and other mammals (Table 2.1).  
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Table 2.1: Cryptosporidium species used in the study and their host specificity.  
Species and isolates Host range Reference(s) 
Cryptosporidium andersoni isolate 30847 Cattle, sheep, bactrian camel, gerbil Liu et al., 2016 
Cryptosporidium hominis isolate TU502_2012 Humans Ifeonu et al., 2016 
Cryptosporidium hominis isolate 30976 Humans Guo et al., 2015 
Cryptosporidium hominis TU502 Humans Xu et al., 2004 
Cryptosporidium hominis UdeA01 Humans Isaza et al., 2015 
Cryptosporidium meleagridis strain UKMEL1 Turkey, chicken, bobwhite quail, dog Ifeonu et al., 2016 
Cryptosporidium parvum Iowa II Mammals, including humans Abrahamsen et al., 2004, Bankier et al., 2003 
Cryptosporidium tyzzeri isolate UGA55 Domestic mice Sateriale et al., 2019 
Cryptosporidium ubiquitum isolate 39726 Deer, sheep, goat, squirrel, mouse Liu et al., 2016 
Cryptosporidium muris RN66 Mice and cats Mc Donald et al., 1992, Uni et al., 1987 
Cryptosporidium baileyi strain TAMU-09Q1 Chickens and Black-headed full Ng et al., 2006, Pavlásek, 1993 
Cryptosporidium viatorum isolate UKVIA1 Humans and rats Elwin et al., 2012, Koehler et al., 2018 
Cryptosporidium sp. chipmunk LX-2015 Mice, squirrels, chipmunks Guo et al., 2015a, Prediger et al., 2017, Stenger et al., 2015 
Cryptosporidium ryanae isolate  45019 Cattle  Fayer et al., 2008 




2.3.2.  Genome Data Mining, Identification and Classification of GSTs 
Cryptosporidium species genomes available at CryptoDB (Heiges et al., 2006) were mined for 
GSTs. Two different methods followed for GST mining. First, the genomes of Cryptosporidium 
species were mined using the term “glutathione transferase” in the search tool. Second, the 
species genomes were blasted with GST proteins from Homo sapiens (protein ID:P08263) 
(Board and Webb, 1987) and C. parvum Iowa II (protein ID: EAK89476.1) (Bankier et al., 2003, 
Abrahamsen et al., 2004). The BLASTP mined proteins revealed a range of apicomplexan 
species which were filtered out to show only Cryptosporidium species. The hit proteins were 
then collected and subjected to protein family analysis using the Pfam (El-Gebali et al., 2019) 
and InterPro (Mitchell et al., 2019) programs. The results were analyzed and the hit proteins 
that were classified as GST by Pfam (PF14497, PF13417 and, PF17172) (El-Gebali et al., 2019) 
and InterPro (IPR036282, IPR004045 and IPR010987) (Mitchell et al., 2019) were selected.  
For the collection of more hits, Cryptosporidium species genomes available at NCBI database 
(Agarwala et al., 2018) was blasted with two GST proteins from C. andersoni 30847 
(cand_012830 & cand_023790) and from C. meleagridis UKMEL1 (CmeUKMEL1_05845) that 
were collected from CryptoDB (Heiges et al., 2006). The hit proteins were screened for GSTs 
following the method described above.  
A final total count was presented by deleting the duplicated GSTs. The selected GSTs were 
then grouped into different classes or groups based on their percentage identity, following 
the conventional criterion of less than 25-30% identity being a new class (Allocati et al., 2009, 
Frova, 2006, Oakley, 2011, Sheehan et al., 2001, Soranzo et al., 2004). 
2.3.3.  Analysis of Homology 
The percentage identity between GSTs was deduced using Clustal Omega (Sievers et al., 
2011). The full-length GSTs were subjected to Clustal analysis which produced the percentage 
identity amongst each of the proteins as matrix identity results. These results were laid out in 





2.3.4. Collection of Different GST Classes’ Protein Sequences  
For comparative analysis, GST protein sequences belonging to different GST classes were 
collected using multiple methods to build a library for phylogenetic analysis. On the European 
Molecular Biology Laboratory (EMBL) site (Madeira et al., 2019), GSTs sequences that are 
placed under the GST superfamily (IPR040079) were retrieved. The GST classes namely CLIC 
(IPR002946), Alpha (IPR003080), Mu class (IPR003081), Pi (IPR003082), Omega (IPR005442), 
Zeta (IPR005955) and Sigma (IPR003083) were collected under EMBL. More sequences were 
obtained through text search using the UniProt protein knowledge base (Consortium, 2019). 
A specific GST class was searched on the site and the hits obtained were further verified using 
Pfam (El-Gebali et al., 2019) and InterPro (Mitchell et al., 2019) to ensure uniformity with the 
GSTs collected from the EMBL site (Madeira et al., 2019). The remaining GSTs that were not 
in the databases were retrieved from published articles. 
The Cryptosporidium species GST sequences along with protein sequences of different GST 
classes used in the phylogenetic analysis are presented in Appendix B. 
2.3.5.  Phylogenetic Analysis 
The GST sequences in supplementary dataset 1 were used to make a phylogenetic tree for 
inferring their evolutionary relationship. First, all the GST protein sequences were aligned by 
MAFFT v6.864 embedded on the Trex-online server (Boc et al., 2012). Then, the alignment 
was automatically submitted to the server for inferring the tree with different models and the 
optimized tree was selected. Finally, the tree was submitted to iTOL for viewing and 
annotation (Letunic and Bork, 2019). Thioredoxin from Oryctolagus cuniculus (protein ID: 
P08628) was used as an outgroup.  
For the construction of the phylogenetic tree of the Cryptosporidium GST proteins, the protein 
sequences were aligned using MUSCLE software (Edgar, 2004) embedded in MEGA7 (Kumar 
et al., 2016). The evolutionary history was inferred by using the maximum likelihood method 
with 100 bootstrap replication based on the JTT matrix-based model (Jones et al., 1992). 





2.3.6. Cellular Localization and Transmembrane Helices Prediction 
Cellular localization of GSTs was predicted using the Bologna Unified Subcellular Component 
Annotator (BUSCA) (Savojardo et al., 2018). BUSCA is the latest, accurate program available 
for the prediction of proteins’ subcellular localization; it integrates different computational 
tools such as identifying signal and transit peptides (DeepSig and TP-pred3), GPI-anchors 
(PredGPI) and transmembrane domains (ENSEMBLE3.0 and BetAware) with tools for 
discriminating subcellular localization of both globular and membrane proteins (BaCelLo, 
MemLociand SChloro) (Savojardo et al., 2018). The outcomes of these different programs 
were processed and integrated to predict subcellular localization of both eukaryotic and 
bacterial proteins (Savojardo et al., 2018). Prediction of transmembrane helices in GSTs was 
done using TMHMM Server v. 2.0 (Möller et al., 2001). This program is well known for its high 
degree of accuracy in the prediction of transmembrane helices and discrimination between 
soluble and membrane proteins.  
2.3.7. Template Identification 
To construct 3D models of proteins, reference protein structures previously solved by 
crystallization or nuclear magnetic resonance (NMR) are needed. These would serve to 
simulate not only the fold of a protein but also a full atom model to build. These proteins are 
referred to as templates. Either single or multiple templates can be used in constructing the 
3D model of a protein (Fiser, 2010). In this study, three different web servers, namely NCBI 
BLAST (v2.10.1) (Altschul et al., 1990), i-TASSER (v5.1) (Yang and Zhang, 2015)  and PHYRE 
(v2.0) (Kelley et al., 2015), were consulted to identify the most suitable templates for GST 
proteins. Based on the highest percentage identity and sequence coverage, the best 
templates were selected for modeling each GST protein. In cases where the templates had 
the same percentage identity and sequence coverage, we selected the template with the 
highest resolution for modelling.  
2.3.8. Protein Sequence Alignment for Modelling 
T-COFFEE webserver (Di Tommaso et al., 2011) was used for aligning the GST proteins and 
the template sequences. The aligned files were downloaded in FASTA format and modified to 




2.3.9. Protein Modelling, Optimization and Validation   
The MODELLER v9.21 program (Webb and Sali, 2016) was used to build GST models. Multiple 
structures were produced by Modeller 9.21. The model with the best DOPE assessment was 
selected as the output structure to be used. The structures modeled were viewed using 
PyMOL (Schrodinger, 2010). The model for each GST was then subjected to evaluation for 
stereochemistry and energetic quality at the Structural Analysis and Verification Server 
(http://servicesn.mbi.ucla.edu/SAVES/) and ProsaII (https://prosa.services.came.sbg.ac.at/) 
(Wiederstein and Sippl, 2007). Based on the validation results, the protein models were then 
refined on the GalaxyWeb Refiner server (Ko et al., 2012). After refinement, the models were 
again subjected to evaluation and validation using programs such as ERRAT (Colovos and 
Yeates, 1993), Verify3D (Eisenberg et al., 1997), PROCHECK (Laskowski et al., 1993, Laskowski 
et al., 2006), and RAMPAGE (Wang et al., 2016) and ProsaII (Wiederstein and Sippl, 2007).  
2.4. Results and Discussion 
2.4.1. Two Different Sizes of GSTs Present in Cryptosporidium Species 
Genome data mining of fifteen Cryptosporidium species revealed the presence of three GST 
genes in each of the species genomes (Table 2.2).  The presence of more than one GST gene 
is common in eukaryotic species (Frova, 2006). Among 45 GSTs, 30 were found to have the 
characteristic GST motifs (Oakley, 2011, Sheehan et al., 2001), such as the N-terminal domain, 
which houses the G site, and C-terminal domain, which determines the substrate specificity 
(H-site) (Table 2.2 and Figure S1). The remaining 15 GSTs have one of the characteristics GST 
motifs indicating either these sequences are diverse or fragmented or not properly annotated 
(Table 2.2). These GSTs were considered incomplete and were not included for further 
analysis unless indicated. Future genome editing and better gene prediction programs will 
help in getting the complete sequences for these GSTs and possibly predicting characteristic 
N- and C-terminal motifs. In total, 30 GSTs were taken for further analysis. Analysis of GST 
protein sizes revealed the presence of two different lengths of GSTs in Cryptosporidium 
species (Table 2.2). One type of GST protein is shorter in size with amino acids ranging 
between 157 and 268, and another type of GST protein is longer in size, with amino acids 
ranging between 373 and 466 (Table 2.2). GSTs from Cryptosporidium species seem to be the 
longest in amino acid length, as most of the GSTs reported in other organisms to date are 200-
250 amino acids in length (Frova, 2006). Furthermore, it can be noted that the addition in 
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length is found only on the outer N- and C-terminal regions, with the center of the protein 
containing the GST-superfamily domains (Table 2.2). In order to assess whether 
Cryptosporidium species GST proteins are indeed properly annotated gene products, we 
further analyzed the gene structure. Interestingly, all the longer GSTs had a single exon, thus 
no introns, but shorter GSTs were the products of one to four exons (Table 2.2). This could be 
indicative of shorter GSTs being prone to having multiple isoforms owing to gene shuffling. 
Due to the presence of these multiple introns, the production of more diverse short GSTs can 




Table 2.2: Glutathione transferase (GST) analysis in Cryptosporidium species. The GST number in column 2 is an indication of the number of GSTs that a specific species 
possesses. Whilst the number on column 3 indicates the group the protein belongs to (based on the percentage identity) (Allocati et al., 2009, Frova, 2006, Oakley, 2011, 




GST number Protein ID  Protein 
size (No of 
Amino 
acids) 






N Terminal C terminal 
Cryptosporidium andersoni isolate 30847 3 GST1 cand_012830$ 197 12-97 95-195 3 exons 
  GST2 cand_023790$ 466 67-149 166-319 1 exon 
  GST3 OII73498.1* 260 - 124-235 1 exon 
Cryptosporidium hominis isolate 
TU502_2012 
3 GST1 ChTU502y2012_407g2365$ 186 1-62 64-186 2 exons 
  GST2 ChTU502y2012_421g0615$ 428 69-151 146-315 1 exon 
  GST3 ChTU502y2012_303g0055/O
LQ15919.1$ 
268 - 153-236 1 exon 
Cryptosporidium hominis isolate 30976 3 GST1 GY17_00002363$   186 1-62 60-183 2 exons 
  GST2 GY17_00000733 $  428 69-151 146-315 1 exon 
  GST3 PPS94453.1* 268 - 152-236 1 exon 
Cryptosporidium hominis TU502 3 GST1 XP_667744.1* 161 1-62 64-161 1 exon 
  GST2 Chro.80347  $ 428 69-151 146-315 1 exon 
44 
 
  GST3 XP_666781.1* 268 - 154-236 1 exon 
        
Cryptosporidium hominis UdeA01 3 GST1 CUV07467.1* 161 1-62 64-161 1 exon 
  GST2 CHUDEA8_2970$ 428 69-151 146-315 1 exon 
  GST3 CUV04748.1* 268 - 154-236 1 exon 
Cryptosporidium meleagridis strain 
UKMEL1 
3 GST1 CmeUKMEL1_03350$   193 9-94 96-193 3 exons 
  GST2 CmeUKMEL1_14570$ 428 69-151 146-315 1 exon 
  GST3 CmeUKMEL1_05845$ 268 31-118 101-243 1 exon 
Cryptosporidium parvum Iowa II 3 GST1 cgd7_4780 $ 186 1-62 60-183 2 exons 
  GST2 cgd8_2970$ 429 69-151 146-315 1 exon 
  GST3 cgd2_3730$ 268 - 156-236 1 exon 
Cryptosporidium tyzzeri isolate UGA55 3 GST1 CTYZ_00001095$   186 1-62 60-186 2 exons 
  GST2 CTYZ_00000322$  429 69-151 146-315 1 exon 
  GST3 TRY52903.1* 268 - 153-236 1 exon 
Cryptosporidium ubiquitum isolate 39726 3 GST1 cubi_03151$ 213 1-89 91-213 4 exons 
  GST2 cubi_03523$  428 69-151 146-315 1 exon 
  GST3 XP_028873506.1* 266 - 159-235 1 exon 
Cryptosporidium muris RN66 3 GST1 XP_002141168.1* 160 1-60 58-158 2 exons 
  GST2 XP_002140043.1* 466 - 211-312 1 exon 
45 
 
  GST3 XP_002142877.1* 260 - 164-233 1 exon 
Cryptosporidium baileyi strain TAMU-09Q1 3 GST1 JIBL01000090.1* 156 1-57 59-156 1 exon 
  GST2 JIBL01000106.1* 390 36-118 113-275 1 exon 
  GST3 JIBL01000138.1* 236 1-87 69-223 1 exon 
Cryptosporidium viatorum isolate UKVIA1 3 GST1 QZWW01000010.1* 161 1-62 64-161 1 exon 
  GST2 QZWW01000018.1* 428 69-151 146-315 1 exon 
  GST3 QZWW01000026.1* 249 - 134-217 1 exon 
Cryptosporidium sp. chipmunk LX-2015 3 GST1 JXRN01000042.1* 205 1-106 108-205 1 exon 
  GST2 JXRN01000009.1* 425 69-151 - 1 exon 
  GST3 JXRN01000023.1* 250 - 135-217 1 exon 
Cryptosporidium ryanae isolate  45019 3 GST1 VHLK01000064.1* 166 - 37-154 1 exon 
  GST2 VHLK01000046.1* 
 
373 36-118 113-274 1 exon 
  GST3 VHLK01000056.1* 230 1-85 89-221 1 exon 
Cryptosporidium bovis isolate 42482 3 GST1 VHIT01000033.1* 147 - 30-142 1 exon 
  GST2 VHIT01000012.1* 376 21-103 98-264 1 exon 
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  GST3 VHIT01000028.1* 227 1-85 98-221 1 exon 
Symbols: $, protein ID from CryptoDatabase; *, protein ID from NCBI database; -, characteristic GST domain not identified.  
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2.4.2. Cryptosporidium Species GSTs Are Cytosolic in Nature 
Most of the GSTs identified in organisms are cytosolic in nature, with the exception of GSTs 
belonging to the classes MAPEG and Kappa (mitochondrial) (Table S1). In order to identify the 
cellular localization, we subjected Cryptosporidium species GST protein sequences to the 
TMHMM Server v. 2.0 for the prediction of transmembrane helices in their structure (Möller 
et al., 2001) and the BUSCA server (Savojardo et al., 2018) for identifying possible localization 
in a cell. TMHMM prediction revealed that none of the Cryptosporidium species GSTs had 
transmembrane helices, indicating they were soluble and thus possibly cytosolic (Table S2). 
To authenticate our results, we also subjected 395 GSTs belonging to 17 different classes to 
TMHMM prediction (Table S3). The TMHMM predicted the presence of no transmembrane 
helices in previously designated cytosolic GSTs, whereas transmembrane helices were 
predicted for previously designated microsomal GSTs (Table S3). This indicated that the 
TMHMM results on the prediction of no transmembrane helices in Cryptosporidium species 
GSTs were in agreement with previous annotations. Furthermore, BUSCA indicated that all 30 
Cryptosporidium species GSTs were cytosolic (Table S4). Based on these in silico results, we 
concluded that the 30 Cryptosporidium species GSTs were cytosolic in nature.  
2.4.3. Cryptosporidium Species GSTs Belongs to New Classes   
Phylogenetic analysis of Cryptosporidium species GSTs revealed that the 30 GSTs could be 
grouped into three different groups (Figure 2.1). The shorter GSTs were grouped together 
(Group 1) and so were the longer GSTs (Group 2). Interestingly, despite the short amino acid 
length, four GSTs diverged from these two groups (Group 3) (Figure 2.1). Analysis of the amino 
acid percentage identity among Cryptosporidium species GSTs further confirmed that they 
indeed belonged to three different groups. Group 1 GSTs shared an amino acid percentage 
identity of 54-100%, whereas groups 2 and 3 shared identities of 48-100% and 42-71%, 
respectively.  Group 3 GSTs had 13-21% identity with Group 2 GSTs and 14-22% identity to 
Group 1 GSTs. The percentage identity between Groups 1 and 2 was 17-25%. This indicates 
that all three groups of Cryptosporidium species GSTs indeed belonged to three different 
classes as the percentage identity between these groups was below 25-30%, qualifying them 
to be their own class (Allocati et al., 2009, Frova, 2006, Oakley, 2011, Sheehan et al., 2001, 
Soranzo et al., 2004).  
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Although the above results clearly indicated that Cryptosporidium species GSTs belong to 
three different groups, it was still not clear whether they fell under one of the GST classes 
described in the literature (Table S1). Thus, the comprehensive phylogenetic analysis of 
proteins belonging to 17 known GST classes and Cryptosporidium species GSTs was carried 
out (Figure 2.2). Phylogenetic analysis revealed that Cryptosporidium species GSTs did not 
align with any of the 17 pre-existing GST classes and formed three new groups (Figure 2.2). 
This clearly indicates that Cryptosporidium species GSTs belong to three different new GST 
classes. Thus, we named groups 1, 2 and 3 of Cryptosporidium GSTs Vega (ϑ), Gamma (γ) and 
Psi (ψ), respectively.  A point to be noted is that all the GST proteins aligned together as per 
their GST class on the phylogenetic tree, indicating our phylogenetic analysis is correct and 
thus we concluded that Cryptosporidium species GSTs indeed belong to new GST classes.      
                                      
Figure 2.1: Phylogenetic analysis of glutathione transferase (GST) proteins from Cryptosporidium species. The 
evolutionary history was inferred by using the maximum likelihood method based on the JTT matrix-based model 
(Jones et al., 1992). Evolutionary analyses were conducted in MEGA7 (Kumar et al., 2016). The percentage of 
trees (bootstrap value) in which the associated taxa clustered together is shown next to the branches. 
 
2.4.4. Cryptosporidium parvum GST1 of Vega Class Has Atypical Thioredoxin-Like Fold 
Identification of three new GST classes in Cryptosporidium species in this study necessitated 
examination of the structural aspects of these new classes to see if any deviations or novel 
folds might be present, compared to the canonical structure of GSTs (Oakley, 2011, Sheehan 
et al., 2001). Analysis of the primary structure revealed that all Cryptosporidium species GSTs 
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have N- and C-terminal regions characteristic of GSTs that usually contain a G-site and H-site 
Oakley, 2011, Sheehan et al., 2001), respectively (Table 2.2 and Figure S1). All GSTs have the 
highly conserved proline amino acid residue (Figure S1) that is part of  the cis-Pro loop 
responsible for connecting the N- and C-terminal regions in order to maintain the GST 
structural integrity (Allocati et al., 1999). It was observed from Figure S1 that Psi class GSTs 
have a Tyr residue in the N-terminal domain in close proximity to the expected active site Tyr. 
The same was observed with the Vega class GSTs with the expectation of C. muris and C. 
baileyi. Vega and Psi GSTs have a few tyrosine residues in the N-terminal region, but they are 
not at a position that is considered part of an active site (Oakley, 2011, Sheehan et al., 2001) 
(Figure S1). Similarly, the majority of the Gamma class GSTs consist of an active site Tyr 
residue with the exception C. andersoni, C. baileyi, C. ryanae and C. bovis species. In these 
species, Phe replaces the active site Tyr residue. Mutagenesis studies have shown that the 
presence of Phe at the supposed position of the active site Tyr significantly reduces the 
catalytic activity. This highlights the critical role played by the active site Tyr in the catalytic 
activity of GST (Liu et al., 1998, Stenberg et al., 1991). The effect of these mutations in the 




Figure 2.2: Phylogenetic tree of the glutathione transferases (GSTs) protein sequences of Cryptosporidium 
species with GSTs from 17 different GST classes. Thioredoxin from Oryctolagus cuniculus (protein ID: P08628) 
is used as an outgroup. Three new GST classes reported in this study from Cryptosporidium species named Vega, 
Gamma and Psi are also shown in the tree. 
 
Multiple sequence alignments of Vega and Gamma GSTs revealed that amino acids in the N- 
and C-terminal regions of these GSTs are highly conserved (Figure S1). For this reason, we 
selected C. parvum GSTs 1 and 2 (CpGST1 and CpGST2) as representative of the Vega and 
Gamma GST classes for structural analysis along with C. meleagridis UKMEL1 GST3 (CmGST3) 
for the Psi class. Structural analysis of the three GSTs was carried out using in silico homology 
modeling. The structural analysis was aimed at assessing only the secondary structural 
elements that are characteristic of GST proteins (Oakley, 2011, Sheehan et al., 2001). These 
GST models are not aimed to assess the binding affinities or the residues involved in binding 
to different ligands. In order to build 3D models we performed a template search at three 
different webpages, namely NCBI (Altschul et al., 1990), PHYRE (Kelley et al., 2015) and I-
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TASSER (Yang and Zhang, 2015). The templates found were of low sequence identity but had 
relatively good coverage (Tables S5). This was expected, since these GSTs are new. We  then 
proceeded to build 3D models using a multiple template method, as this approach is known 
to improve the quality of homology models (Larsson et al., 2008). We built 3D models for all 
three GSTs, attempting single and multiple templates, while also using different combinations 
of the available templates listed in Table S5. The best 3D models with good quality closest to 
the templates were chosen for the structural analysis.  
Here, we present the combination of templates that gave CpGST1, CpGST2 and CmGST3 
models. The templates used to model CpGST1 were a Bombyx mori Sigma class GST (3VPQ-A) 
(Yamamoto et al., 2013) that had 94% coverage and 26% identity and a Penaeus vannamei 
Mu class (5AN1-A) (Juárez‐Martínez et al., 2017) with 98% coverage and 23% identity (Figure 
2.3 and Table S5). For CpGST2 the templates were both from Homo sapiens Alpha class (1K3Y-
B) (Le Trong et al., 2002) and Pi class (19GS-A) (Oakley et al., 1999), with sequence identity at 
21%, coverage at 94% and 22% identity and 84% coverage (Figure 2.4 Table S5), respectively. 
The CmGST3 templates used were from Caenorhabditis elegans Pi class GST (1ZL9-A) 
(https://www.rcsb.org/structure/1ZL9) with 94% coverage and 21% identity and a Homo 
sapiens Alpha class (1K3Y-B) (Le Trong et al., 2002) with 98 % coverage and  22% identity 
(Figure 2.5 and Table S5). 
For each GST, 20 models were built using the MODELLER v9.21 program (Webb and Sali, 
2016). The best model evaluated by DOPE score was selected and subjected to structural 
quality analysis. The selected model for each GST was then refined on the GalaxyWeb Refiner 
server (Ko et al., 2012) and further subjected to structural quality evaluation using different 
programs such as ERRAT (Colovos and Yeates, 1993), Verify3D (Eisenberg et al., 1997), 
PROCHECK (Laskowski et al., 1993, Laskowski et al., 2006), RAMPAGE (Wang et al., 2016) and 
ProsaII (Wiederstein and Sippl, 2007). The overall quality of the models was assessed by the 
combination of these programs’ values and by comparing these with the templates’ structural 
evaluation scores (Tables S6 and S7). The models generated for CpGST1 and CpGST2 were 
found to be of good quality, as different structural validation programs indicated that the 
quality of the model structures was close to the quality of the template structures (Tables S6 
and S7). The model generated for CmGST3 had all parameters in acceptable range including 
Z-score of -3.68 indicating the model is of good quality with the exception of Verify3D where 
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26% residues had an average 3D-1D score > 0.2 (Tables S6 and S7). The three GST models 
generated in the study, along with their corresponding sequence alignments with their 
templates, are presented in Figures 3-5.  
 
Figure 2.3: In silico structural analysis of Vega class representative Cryptosporidium parvum glutathione 
transferase 1 (CpGST1). 3D model of CpGST1 (A) and its amino acid sequence alignment with templates (B). 
Secondary structural annotations were done as per modeled structure where α-helices and corresponding 
amino acids are colored in red while the β-sheets and their corresponding amino acids are colored in yellow. 
The active-site tyrosine and the cis-proline residues are boxed in purple and grey respectively. The template 
Protein Data Bank codes, 3VPQ-A and 5AN1-A, represents GST protein crystal structures from Bombyx mori 
(Sigma class GST) and Penaeus vannamei (Mu class GST). 
 
Structural analysis revealed the presence of 2β-sheets and 3α-helices in the N-terminal region 
and 6α-helices in the C-terminal region of CpGST1 (Figure 2.3). The overall structure of 
CpGST1 at the N-terminal domain seems completely different compared to the canonical GST 
N-terminal domain (Oakley, 2011, Sheehan et al., 2001). The N-terminal region of CpGST1 did 
not have the typical thioredoxin-like fold, nor did it follow the βαβ-α-ββα motif; it was rather 
composed of two antiparallel β-sheets and 3α-helices (Figure 2.3). It is rare to find GSTs that 
do not possess the conventional thioredoxin βαβ-α-ββα motif. Kappa class GSTs, which are 
mitochondrial GSTs, are the closest GSTs that do not follow the traditional thioredoxin fold 
but have still been found to carry out a similar molecular function as conical GSTs (Atkinson 
and Babbitt, 2009, Ladner et al., 2004, Lallement et al., 2014). This is also common for MAPEG 
GST and the mPGES-1 (microsomal ProstaGlandin E-Synthase type 1) subfamily of proteins, 
as they too are a group of structurally unrelated proteins with GSH transferase activities 
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(Frova, 2006, Lallement et al., 2014). Because the GST superfamily shares such vast variations 
in terms of their structural conformation, this ααββα conformation of CpGST1 can be 
considered a unique Vega class feature.  
 
Figure 2.4: In silico structural analysis of Gamma class representative Cryptosporidium parvum glutathione 
transferase 2 (CpGST2). 3D model of CpGST2 (A) and its amino acid sequence alignment with templates (B). 
Secondary structural annotations were done as per modeled structure where α-helices and corresponding 
amino acids are colored in red while the β-sheets and their corresponding amino acids are colored in yellow. 
The active-site tyrosine and the cis-proline residues are boxed in purple and grey respectively. The template 
Protein Data Bank codes, 1K3Y-B and 19GS-A, represents GST protein crystal structures of Alpha class (1K3Y-B) 
and Pi class (19GS-A) GSTs from humans. 
 
In contrast to the CpGST1 model, the CpGST2 and CmGST3 models N-terminal domain follows 
the thioredoxin-like fold, which is characteristic of cytosolic enzymes in the GST superfamily 
(Oakley, 2011, Sheehan et al., 2001, Wilce and Parker, 1994). The N-terminal domain was 
complete with 4β-sheets and 3α-helices following a βαβ and ββα arrangement with the two 
motifs linked by an α2 (Figures 4 and 5). The C-terminal domain contains helices with each 
model CpGST2 and CmGST3 having a varying number of helices (Figures 2.4 and 2.5). It has 
been suggested that an increase in the number of helices in the C-terminal domain, may allow 
for a broader substrate range and/or offer a deeper catalytic pocket that facilitates the 




Figure 2.5: In silico structural analysis of Psi class representative Cryptosporidium meleagridis strain UKMEL1 
GST3 glutathione transferase 3 (CpGST3). 3D model of CmGST3 (A) and its amino acid sequence alignment with 
templates (B). Secondary structural annotations were done as per modeled structure where α-helices and 
corresponding amino acids are colored in red while the β-sheets and their corresponding amino acids are colored 
in yellow. The active-site tyrosine and the cis-proline residues are boxed in purple and grey respectively.   The 
template Protein Data Bank codes, 1K3Y-B and 1ZL9-A, represents GST protein crystal structures from Human 
(Alpha class GST) and Caenorhabditis elegans (Pi class GST). 
 
2.5. Conclusion 
In this genomic era, in silico based comparative studies at genome level or at protein family 
level have become an important tool to uncover novel aspects in organisms. This study is such 
an example, where genomes of Cryptosporidium species were mined for glutathione 
transferases (GSTs), enzymes playing a key role in cellular defence and detoxification that are 
also a potential drug target against pathogens and metabolic disorders. Analysis revealed an 
interesting feature, namely the presence of two different sizes of GSTs (short and long) in 
these species. The longer GST proteins were found to be longer than the GSTs found in other 
organisms, with the size attributed to C- and N-terminal extensions. One of the major findings 
of the study is the identification of GSTs belonging to three new GST classes in 
Cryptosporidium species. In addition, Cryptosporidium parvum GST1 had an atypical 
thioredoxin fold in the N-terminal region with an αα-ββ-α motif rather than the typical 
thioredoxin-like fold with a βαβ-α-ββα motif. Future studies includes functional and structural 
(X-ray or NMR) characterization of Cryptosporidium species GSTs. The study results serve as 
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3.1. Abstract 
Glutathione transferases (GSTs) from Cryptosporidium species are a newly classified group of 
proteins thought to be key to the survival of Cryptosporidium spp. However not much is 
known about structure and function of this parasitic GST. GSTs are a family of multifunctional 
proteins which belong to phase II detoxifaction group of enzyme. They function to catalyze 
the nucleophilic conjugation of previously reduced glutathione thiol group to the electrophilic 
substrate converting them to less harmful more soluble compounds. Here we report the 
recombinant overexpression and purification of a gamma class Cryptosporidium parvum GST2 
protein using Escherichia coli. Several expression vectors were tested for the expression of 
high yields of soluble GST protein. GST was successfully overexpressed in E. coli BL21 (DE3) 
cells using a pCOLD-derived vector with a molecular chaperon trigger factor and N-terminal 
His-tag. The expressed protein was purified to homogeneity using affinity and gel filtration 
chromatography. The gel filtration further revealed the Cryptosporidium GST under native 
conditions are dimeric, much like the pre-existing GSTs. The successful purification of GST 
paves the way for structural and functional characterization studies, which will be essential 
to understand the structure and function of these newly identified enzymes.  
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Cryptosporidium spp. are an intracellular group of apicomplexan protists, responsible for the 
contraction of a mild to severe gastro-intestinal disease called cryptosporidiosis (Certad et al., 
2017). This disease is both zoonotic and anthroponotic in its transmission and poses a large 
threat on socio economic and developmental growth in struggling third world countries (Xiao 
and Feng, 2008).  
A system present in all the Cryptosporidium spp. with great potential for cryptosporidiosis 
intervention is the detoxification system (Abrahamsen et al., 2004). This system is comprised 
of phase I and phase II drug metabolizing enzymes in conjunction with phase III transporters, 
which safely detoxify and eliminate a wide range of xenobiotic compounds. Glutathione 
transferases (GST) are amongst the phase II detoxification enzymes that bacterial and 
eukaryotic species use in this system (Frova, 2006, Xu et al., 2005). They primarily function to 
catalyse the nucleophilic addition of a reduced glutathione (GSH) thiol group to the 
electrophilic centres of organic xenobiotic compounds. This allows the compounds to be more 
soluble and less toxic so to be compartmentalized and eliminated by phase III transporter 
enzymes or excreted, protecting the cells from cytotoxic compounds in the process (Hayes et 
al., 2005). Depending on the class of GST enzymes, some might have additional functions, 
serving as isomerases, thiol transferases, peroxidases, being involved in prostaglandin 
synthesis and other non-catalytic functions (Sheehan et al., 2001). In the context of 
Cryptosporidium GST, both the catalytic and non catalytic functions are yet to be established 
due to this enzyme being recently discovered. Also, from the bioinformatics studies it can be 
anticipated that the Cryptosporidium GSTs would have novel functions due to the extreme 
divergence in amino acid similarity and structural difference when compared to pre-existing 
GSTs (Mfeka et al., 2020). 
 Wide genome mining of Cryptosporidium spp. had showed that of three GST genes present 
in this species, CpGST2 was the only GST that had the active site tyrosine in the expected 
active site position and encompassed the traditional GST structural features (Mfeka et al., 
2020). This GST was selected for further expression and purification studies as it had a close 
resemblance of the existing GST classes. Moreover, this specific GST is reported to be 
expressed in all stages of the parasites lifecycle and associated with a rapid turnover of MDR 
cases ( Liu et al., 2001, Mauzy et al., 2012). Additionally, the presence of this enzyme in all 
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stages of the parasites life cycle makes it a suitable drug target to treat the disease at any 
time once detected (Mauzy et al., 2012). 
Escherichia coli is a largely popular expression system providing high level production of 
recombinant proteins for structural genomics and proteomics however, the system does 
garner a few complications (Wingfield, 2015). The most frequently experienced being the 
production of recombinant proteins in the form of inclusion bodies (Butt et al., 2005). Similar 
complications were experienced in attempts to fulfil the aim of this study which was to bridge 
the research gap about these scarcely covered Cryptosporidium GSTs through expression and 
purification. In this study, the GST was cloned into a pET11 vector and pCOLD vectors which 
contain cold shock proteins and trigger factor chaperones to help protein production and 
correct folding in a soluble form. This protein was then purified to examine the 




3.3. Materials and Methods 
3.3.1.  Materials 
Genomic/ plasmid work: Acrylamide, agarose and MgCl2 (Merck, RSA). Agar bacteriological, 1 
Kb DNA ladder, gel loading dye, purple, OneTaq® 2x master mix with standard buffer, 
restriction enzymes BamH1 High Fidelity®, Nde1 and restriction enzyme buffer Cut smart® 
buffer (New England Biolabs, USA). GeneJET Pmasmid Miniprep Kit, FastRuler middle range 
DNA ladder and GeneRuler 1Kb DNA ladder (ThermoFisher Scientific, USA). EZ-Vision™ Blue 
light DNA Dye (VWR Life Sciences, USA). 
Protein expression:   NaCl (Merck, RSA). Pancreatic digest of casein (tryptone), yeast extract 
and blue prestained protein standard, broad range (New England Biolabs, USA). Lysozyme 
(Sigma-Aldrich, USA). The gel filtration standards (Bio-Rad, USA). IPTG and ampicillin 
(Glentham Life Sciences, UK). 
Protein purification: glycine, Imidazole, KCl, K2PO4, KH2PO4, NaCl, Tris (hydroxymethyl 
aminomethane) (Merck, RSA). NaOH, NaPOH2 (Sigma-Aldrich, USA). 
Protein visualization: bromophenol blue, commassie brilliant blue R250, sodium dodecyl 
sulfate (SDS), ethylenediamininetetraacetric acid (EDTA) and glycine (Merck, RSA). Acetic 
acid, methanol, ethyl acetate, TEMED, 2-mercaptoethanol and BLUeye prestained ladder 
(Sigma-Aldrich, USA). PageRuler® prestained protein ladder (ThermoFisher Scientific, USA), 
Ammonium persulfate (Bio-Rad, USA).  
All other reagents and chemicals used were of analytical grade.  
 
Escherichia coli cell lines:  
E. coli JM109 from Sigma-Aldrich (USA) were used for plasmid storage. E. coli BL21 (DE3) from 
ThermoFisher Scientific (USA) were used for colony PCR and recombinant protein expression. 
Constructs:  
The genomic GST coding sequence of Cryptosporidium parvum CryptoDB (transcript ID: 
cgd8_2970) was synthesized by GenScript (USA) and cloned into pCOLD1 (TaKaRa) and 
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pCOLDTF (TaKaRa) within the BamH1 and Nde1 restriction sites. pET11-CpGST was gifted by 
Dr Ikechukwu which was also synthesized by GenScript. 
Equipment: The incubators used were the orbital shaker incubator MRC (RSA) and still 
incubator from Merck (USA). The vortex used was the Vortex genie 2, purchased from 
Scientific Industries (USA) and the digital heat block from Beckman was used. The magnetic 
stirrer was purchased from Labs-Mart (CA). The pH meter Starter 2100 was from OHAUS (UK), 
precision balance series scale from LABOTEC (RSA) and the endure electrophoresis system 
was from Labnet International (USA). The power pac used was from Bio-Rad (USA). The 
centrifuges used were the UV mini 1240 UV-Vis spectrophotometer from SHIMADZU (JPN) 
and the V-630 Absorbance spectrophotometer from JASCO (USA). The centrifuges used were 
the spectrafuge 16M from Labnet International (USA), Avanti® J-26 XPI centrifuge from 
Beckman Coulter (USA). The sonicator and the NanoDrop 200 spectrophotometer was from 
ThermoFisher Scientific (USA). For PCR the T100™ Thermal cycle from Bio-Rad (USA) was 
used. For capturing gel images the G:BOX was used from Syngene (INDIA). The columns used 
for protein purification were the HisTrap FF 5 mL column packed with Ni 2+ Sepharose 6 Fast 
Flow purchased from Merck (USA) and the HiPrep™ 16/60 Sephacryl® S-200 HR prepacked gel 
filtration column from GE-Healthcare (USA). The columns were connected to the ÄKTA start 
from GE Healthcare (USA). The purification samples were concentrated in the Amicon® Ultra-
2 Centrifugal Filters purchased from Sigma-Aldrich (USA). 
3.3.2.  Methods 
3.3.2.1. Preparation of Competent E. coli Cells: 
A vial of E. coli JM109 cells glycerol stocks was spread plated across 2 x YT agar plate (1.6 % 
(w/v) tryptone, 1 % (w/v) yeast extract, 0.5 % (w/v) NaCl, 1.5% (w/v) agar bacteriological. 
Without flaming the hockey stick shaped glass rod, the rod was aseptically spread across four 
other plates to dilute the bacteria to obtain single colonies. An additional sixth  2 x YT agar 
plate was left un-inoculated as a media sterility control. The plates were then inverted and 
incubated for 16 h at 37 °C. A single colony was then selected from plate five and inoculated 
into 50 mL 2 x YT media to be incubated for another 16 h at 37 °C shaking at 200 rotations per 
minute (rpm). The overnight culture was then diluted into a 1:20 in 2 x YT media and grown 
to OD600 ~ 0.4-0,6. The sample was then centrifuged at 5000 x g for 10 min at 4 °C. The pellet 
was resuspended in 10 mL MgCl2 (100 mM) and incubated in ice for 4 h.  The sample was then 
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centrifuged again under the same conditions followed by the resuspension of the pellet once 
again with 1 mL CaCl2 (100 mM) and 1 mL glycerol (80 % v/v). The cells were then sub-
aliquoted into sterile sample tubes and stored at -80 °C for further use. The same procedure 
was executed for E. coli BL21 (DE3) cells. 
3.3.2.2. Transformation of Gene Constructs Into E. coli Cells: 
The gene constructs of CpGST were resuspended in miliQ water to get a final concentration 
of 173 ng/µL of CpGST-pET11a, 264 ng/ µL  of CpGST1-CpGST and 251 ng/ µL  of pCOLDTF-
CpGST.  
The constructs were transformed into competent E. coli JM109 cells for storage and 
propagation and into E. coli BL21(DE3) for expression. For the transformation process, 20 µL 
of the competent cells were incubated with 1  µL of the gene constructs in ice for 30 min. The 
cells were then heat shocked at 42 °C for 90 s with a heating block and cooled rapidly on ice 
for 2 min. Proceeding this was incubation with nutrient rich media at 37 °C for 1 h, which is 
used for optimum growth competent cells for efficient transformation. This media was 
prewarmed SOC media (2% (w/v) tryptone, 0.5% (w/v) yeast extract, 250 mM KCl, 1 M 
glucose, 2 M MgCl2). Thereafter the cells were spread plated aseptically into 2 x YT selection 
agar plates containing 50 µg/mL ampicillin and incubated overnight at 37 °C. 
3.3.2.3. Plasmid DNA Isolation 
After transformation of the gene constructs into E. coli JM109 for plasmid storage and 
propagation, a single colony was inoculated into 5 mL of 2 x YT media supplemented with 50 
mg/µL ampicillin. The inoculate was grown overnight at 37°C, 200 rpm. Thereafter the cells 
were collected through centrifugation at 12 000 x g for 10 min. The plasmid DNA was then 
harvested using the Thermo Scientific GeneJET Plasmid Miniprep Kit as per the manufacturer 
instructions. To determine the concentration of the plasmid DNA isolated the NanoDrop 
spectrophotometer was used. 
3.3.2.4. Restriction Digest of Mini Prepped Plasmid Isolates  
To confirm the presence of the CpGST insert in the pET and pCOLD vectors that were 
previously isolated a restriction digest was performed. The plasmid DNA (1 µg) was incubated 
with BamH1-HF for a single digest and BamH1-HF with Nde1 for a double digest along with 
the cut smart buffer and milliQ water to make up a volume of 25 µL in sterile sample tubes. 
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The tubes were incubated for an hour at 37°C. The restriction enzyme digest was terminated 
by addition of  loading dye into digestion reaction. The restriction enzyme products were 
electrophorized on an agarose gel (0.75 % (w/v) agarose, 40 mM Tris, 20mM acetic acid, 1 
mM EDTA, pH 8.3). This was done alongside a 1 Kb DNA ladder at 80V using the Bio-Rad power 
pac. The gel was visualized using the G box imaging system. The standard curves used for gel 
analysis are on Appendix C Figure S2. 
3.3.2.5. Primer selection  
The pCOLD vector primers were used for DNA amplification. The coding sequence of both the 
pCOLD1 and pCOLDTF were obtained from Genscript. The coding sequences selected for the 
primers were a few base pairs upstream and downstream the restriction enzyme sites. 
Primers were obtained from Inqaba Biotechnical Industries. The vectors shared the same 
primer sequence as taken from the TaKaRa (JPN). Thermocalc which is a confirmation 
software was used to determine whether self-complementary regions appeared and the 
annealing temperatures of the primers (Andersson et al., 2002). The primers synthesized 
were as follows: 
Table 3.1: pCOLD primers synthesized at Inqaba Biotechnical Industries 
Primer name Sequence 5’-3’ Melting temperature 
pCOLDTF Forward CCACTTTCAACGAGCTGATG 51.78 °C 
pCOLD1 Forward ACGCCATATCGCCGAAAGG 53.25  °C 
pCOLD Reverse GGCAGGGATCTTAGATTCTG 51.78 °C 
 
3.3.2.5.1. Colony PCR 
To confirm the presence of the pCOLD-CpGST insert in the transformed E. coli BL21(DE3) a 
colony PCR was used. Five colonies were picked from each of the selection plates containing 
the newly transformed E. coli BL21(DE3) cells with pCOLD1-CpGST and pCOLDTF-CpGST. The 
colonies were diluted with 10 µL of nuclease free distilled water. Thereafter the Taq 2X 
Master Mix was used with the components in Table 3.2. The PCR product was run on a 1% 
agarose gel and was visualized using the G box imaging system. The standard curves used 





Table 3.2: Colony PCR components 
Components Volume (µL) Final concentration 
Forward primer (10 µM)  0.5 0.2 µM 
Reverse primer (10 µM) 0.5 0.2 µM 
Template DNA 2 < 1 µg 
Taq 2X Master Mix 12.5 1 X 
Nuclease free water 9.5 __ 
The template DNA was amplified using the following conditions; 95 °C for 30 sec, followed by 30 cycles of (95 
°C for 15 sec, 46 °C for 15 sec, 68 °C for 90 sec) with the final extension being at 68 °C for 5 min. The PCR 
products were visualised on an agarose gel (1 % (w/v) agarose, 40 mM Tris, 20mM acetic acid, 1 mM EDTA, 
pH8.3) run alongside a FastRuler middle range DNA Ladder (ThermoFisher Scientific, USA). 
3.3.2.6. Recombinant Expression of CpGST 
For the recombinant expression of CpGST, E. coli BL21 (DE3) cells were transformed with 
pET11a-CpGST, pCOLD1-CpGST and pCOLDTF-CpGST as explained in section 3.2.2. Single 
colonies were selected to be inoculated overnight in 10 mL of 2 x YT broth supplemented with 
50 µg/mL ampicillin (37°C at 200 rpm, 16 h). The overnight cultures were then diluted in 1:100 
with fresh 2 x YT broth supplemented with 100 µg/mL ampicillin and incubated once more 
(37°C at 200 rpm). At mid-log phase A600 - (0.6-0.8), the cells with the pET vectors were 
induced with isopropyl-β-D-1-thiogalactopyranoside (IPTG) at varying concentrations (1 mM, 
3 mM and 5 mM) with the induction time varying as well (4h, 8h and 16h). Thereafter the 
cultures were incubated (37°C at 200 rpm). The cells with the pCOLD vectors at mid-log phase 
A600 - (0.6-0.8), were cold shocked for 30 min in a 15°C water bath. Thereafter the cultures 
were induced with IPTG to a final concentration of 1 mM. The cells were then incubated for 
24 h (15°C at 200 rpm). Before harvesting the cells, 50 mL samples were put aside for sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis and then harvested 
separately by centrifugation at 6000 x g for 15 min at 4°C. The supernatant was discarded 
with the pellets stored at -80 °C for the promotion of cell lysis or until they were used for 
CpGST purification.  
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The samples separated for gel analysis as done by Laemmli (1970) were thawed at room 
temperature and resuspended in phosphate buffered saline (1X, pH 7.4, 137 mM NaCl, 2.7 
mM KCl, 8 mM Na2HPO4, and 2 mM KH2PO4). Thereafter lysozyme (1 mg/mL) was 
supplemented to the suspension and incubated for 30 min at 37 °C. The samples were further 
lysed on ice by sonification (30 sec x 8). The soluble and insoluble fractions were then 
harvested by centrifugation at 10 000 x g for 30 minutes. The pellet contained the insoluble 
fraction while the supernatant contained the soluble fraction. The expression samples were 
then analysed using 12.5 % SDS PAGE as described by Laemmli (1970). 
3.3.2.7. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Prior to loading, all samples were denatured by boiling with reducing treatment (125 mM Tris-
HCl, 4 % (w/v) SDS, 20 % (v/v) glycerol, 10 % (v/v) 2-mercaptoethanol) for 3 min and cooled 
on ice until loaded. The gels were connected to a BIO-RAD PowerPac TM and protein 
separation occurred at 40 V, 18 mA per gel in tank buffer (250 mM Tris-HCl, 192 mM glycine, 
0.1 (w/v) SDS, pH 8.3). The gels were then stained overnight with staining solution (0.125 % 
(w/v) coomassie blue R-250, 50 % (v/v) methanol, 10 % (v/v) acetic acid. They were then 
destained overnight with destaining solution (50 % (v/v) methanol, 10 % (v/v) acetic acid) until 
background was clear and captured with the G-Box imaging system. 
3.3.2.8. Purification 
The pellet from expression was thawed on ice. Five grams of the harvested cells were 
resuspended in 10 mL of buffer 1 (50 mM Tris-HCl, 500 mM NaCl, 15mM Imidazole, 0.02% 
NaN3,  pH 7.5,) to optimize protein binding to the column. The cell suspension was lysed by 
sonication on ice (8 x 30 sec) and centrifuged at 10 000 x g for 30 minutes. The soluble fraction 
(supernatant) was then diluted to 50 mL and subjected to immobilized metal affinity 
chromatography (IMAC) using the HisTrap FF column. The column was washed with milliQ 
water and pre-equilibrated with 5 column volumes of buffer 1. The supernatant was then 
passed through the column followed by 10 column volumes of buffer 1 to wash away any 
unbound proteins. The bound protein was eluted with increasing concentrations of imidazole 
starting with buffer 2 (50 mM Tris-HCl, 500 mM NaCl, 50 mM Imidazole, 0.02% NaN3, pH 7.5). 
Thereafter buffer 3 (50 mM Tris-HCl, 500 mM NaCl, 150 mM Imidazole, 0.02% NaN3, pH 7.5) 
and buffer 4 (50 mM Tris-HCl, 500 mM NaCl, 250 mM Imidazole, 0.02% NaN3, pH 7.5) were 
used to elute strongly bound proteins. 1.0 mL fractions were collected. The harvested cell 
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pellet, supernatant, flow through, wash and eluents were analysed using reducing SDS-PAGE 
as previously described in section 3.3.2.7. The standard curves used for gel analysis are on 
Appendix C Figure S4. 
3.3.2.9. Size Exclusion Chromatography (SEC) 
The IMAC purified protein samples eluted using buffer 4 was pooled together and subjected 
to buffer exchange in preparation for size exclusion chromatography. The sample was buffer 
exchanged overnight at 4 °C against buffer 5 (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.02% 
NaN3). The buffer exchanged sample was then concentrated using centrifugal filters which 
was spun down at 5000 x g for 30 min. The sephacryl S-200 column (120mL with a flow rate 
of 0.5mL/min) was washed with 5 column volumes of MilliQ water and equilibrated with a 
further 5 column volumes of buffer 5. Thereafter 500 µL  of the concentrated sample was 
pumped into the column and further washed with 1.5 column volumes of buffer 5. The eluted 
proteins were monitored at 280 nm with the absorbance detected through the ÄKTA start. 
0.5 mL samples were collected with the peaks analysed using reducing SDS-PAGE as 
previously described in section 3.3.2.7. The standard curve used for gel analysis are on 
Appendix C Figure S5. 
3.3.2.10. Protein Concentration Determination 
The protein concentration was determined spectrophotometrically using Beer-Lamberts 
Law 
𝑨 = 𝜺λcl                                                                                                                                   Equation 1 
Where 𝜀λ is the molar absorption coefficient at λ, c is the concentration and l is the pathlength 
of the light through the solution. The molar absorption coefficient of trigger factor-CpGST was 
determined using equation 2: 
ε(M-1cm-1) = 5500 (∑ Trp) + 1340 (∑ Tyr) + 150 (∑ Cys)                                               Equation 2 
where ∑ Trp) is the sum of the tryptophan residues, ∑ Tyr is the sum of the tyrosine residues 
and ∑ Cys  is the sum of the cysteine residues all within the protein. The constants are 
representative of molar absorption coefficients for the mentioned residues. The molar 
absorption coefficient at 280 nm for CpGST with the trigger factor and the cleavage site was 




Integrating bioinformatics and wet lab experimentation was done for a more focused, well 
rounded investigation into Gamma CpGST2 hereon referred to as CpGST. Seeing that the 
expression, purification and characterization of this protein has never been reported on, here 
the CpGST gene was cloned into various vectors for optimum recombinant expression.  
Subsequently, pCOLD vectors were then used to express the CpGST. Before the expression 
studies were conducted, the CpGST constructs received from GeneScript were confirmed 
using restriction digest and colony PCR. This step was necessary to ensure that the correct 
construct was used.   
3.4.1. CpGST Confirmation 
To confirm the presence of the CpGST inserts within the respective pCOLD and pET vectors a 
restriction enzyme digest was performed. All the gene constructs were single digested with 
BamH1 to confirm the construct size and double digested with BamH1 and Nde1 to release 
the CpGST gene from the vectors. Figure 3.1 shows the undigested plasmid from the three 
constructs (pET11a-CpGST, pCOLD1-CpGST and pCOLDTF-CpGST) consists of three to four 
bands of varying intensities as expected for circular DNA taking up multiple conformations on 
an agarose gel (Snustad and Simmons, 2015). A single digest of the CpGST contructs resulted 
in the band size that corresponds to the size of the plasmid with the CpGST insert. For an 
example, a single digest of pET11a-CpGST shows a band size of approximately 7144 bp which 
equals to size of pET 11a vector (5675 bp) plus a CpGST gene  (1299 bp). The double digested 
CpGST constructs with BamH1 and NdeI showed two bands with different sizes. The higher 
and lower molecular weight bands corresponds to the size of the vector and the CpGST gene, 
respectively (Figure 3.1). Therefore, the results obtained from restriction digests confirmed 
the presence of the CpGST gene in both pET11a and pCOLD derived vectors.  
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Figure 3.1:  Restriction enzyme digests of gene constructs pET11a-CpGST, pCOLD1-CpGST and pCOLDTF-CpGST 
cut with BamHl and Ndel evaluated on 0.75 % agarose gel. The restriction digested samples of the plasmid 
isolates of pET 11a-CpGST, pCOLD1-CpGST and pCOLDTF-CpGST shown in A, B and C respectively. The CpGST 
construct were single digested with BamH1 and double digested with  BamH1 and Nde1 for 1 h. The samples 
loaded in the agarose gels were the undigested, BamH1 single digested and the double digested gene contructs 
with BamH1 and NdeI respectively.  
 
Prior to expression studies, the CpGST constructs were transformed to E.coli BL21 (DE3) 
expression cell line and the resulting transformants were screened for the presence of CpGST 
plasmid using colony PCR. Figure 3.2 confirms that the selected transformants contained the 
plasmid of interest. Figure 3.2a, showed that the insert size in pCOLD1 was 1584 bp while 
Figure 3.2b, revealed that the size of the insert in pCOLDTF was 1704 bp. The obtained insert 
size in both pCOLD1 and pCOLDTF were not same. Furthermore, the sizes obtained were 
larger than the size of the CpGST gene which is 1299 bp. The difference in size of insert is 
attributed to the fact that vector primers were used instead of specific gene primers. The 
forward primer anneals upstream the trigger factor coding sequence as pointed out in 
Appendix C Figure S6 and the reverse primer anneals downstream the multiple cloning site 
thus resulting in the amplification of additional bps flanking the anealation sites. Screening of 
pET11a-CpGST transformant was not done due to the lack of pET forward and reverse primers 







Figure 3.5:  Reducing SDS-PAGE analysis of pCOLDTF-CpGST affinity chromatography purification. The soluble 
expression sample was purified using a HisTrap FF column and the bound protein was eluted using an imidazole 
containing buffer. The proteins eluted had two prominent proteins which were approximately 100 kDa in size. 
A: SDS-PAGE gel of IMAC purification. The lanes were labelled as (MWM) molecular weight marker; (FT) flow 
through and the elution buffers (50 mM Tris-HCl, 500 mM NaCl, 0.02% NaN3, pH 7.5) with increasing 
concentrations of imidazole from 15-250 mM. B: Elution profile of expressed CpGST captured using the ÄKTA 
start. 
 
To further purify the CpGST which eluted from the affinity column, the eluent collected at 250 
mM imidazole was pooled and concentrated to 1.5 mL and loaded into the gel filtration 
column. The gel filtration elution profile in Figure 3.6b shows two peaks. The molecular weight 
of the protein/s in the first peak is ~ 200 kDa. This size correlates with the theoretical size of 
a dimerized CpGST tagged with the trigger factor (47 kDa). In fact when this sample was ran 
reducing SDS-page gel, interestingly two bands of about similar molecular weight (100 kDa) 
were observed. The larger of the two proteins band suggests that CpGST under native 
condition forms a homodimer resulting in the 200 kDa sized protein. It is unclear at this stage 
whether the smaller sized protein also ~100 kDa is a contaminating protein or a partially 





Figure 3.7: UV Scan of IMAC purified pCOLDTF-CpGST within a range of 240-340 nm.  The purified protein was 
initially diluted (1:50) followed by the scan being taken across a 240-340 nm range to determine any impurities. 
The highest peak observed was at 277 nm and no other peaks were seen thereafter. 
 
3.4.4. Protein Concentration Determination 
  
Once the purity was confirmed, the protein concentration was determined. Typically a 
Bradford assay could have been used. However to get a true quantification, clear of any bias 
or possible false positives, the predicted molar extinction coefficient at A280 was used. A single 
microcentrifuge tube containing the eluted sample was used for the duration of the project. 
A serial dilution of the protein was performed, and the absorbance of the samples were taken 
in accumulations of three at 280 nm. The absorbance values were corrected against the blank 
and the plot seen in Figure 3.8 was used to determine the concentration of trigger factor 
tagged CpGST. The calculation took into consideration the trigger factor tagged CpGST and 









Glutathione transferases are a promising set of proteins to target in attempts to treat 
cryptosporidiosis. Their detoxification abilities enables the parasitic cells to reduce a wide 
range of xenobiotic compounds to less toxic, less soluble substances whilst continuously 
propagating within the host (Frova, 2006). Although there is an abundance of information of 
GSTs, much is yet to be discovered about Cryptosporidium GSTs. Thus cloning, expression and 
purification techniques were used in this study to reveal more about the Cryptosporidium 
parvum Glutathione transferase 2 protein found to bear the most resemblance to pre-existing 
GSTs.  
The CpGST gene was then cloned into three vectors, namely pET11a, pCOLD1 and pCOLDTF 
to obtain the best system suitable for CpGST expression. Both PCR and restriction digest 
experiments successfully confirmed the presence of the inserts in the respective vectors 
(Figure 3.1 and 3.2). In both experiments, the gene size obtained was consistent with the 
theoretical CpGST gene reported in the Cryptosporidium database (http://CryptoDB.org) and 
expasy (Gasteiger et al., 2005). 
The CpGST protein was then recombinantly expressed in the before mentioned pET, pCOLD1 
and pCOLFTF vectors. pET vector systems were initially utilized as they are reported to be one 
of the most powerful, efficient systems for recombinant expression in E. coli cells (Bernaudat 
et al., 2011). The utilization of the T7 RNA polymerase promoter within these vectors allows 
for the tight regulation of high yield transcripts (Studier et al., 2009). The expression trials 
carried out using the pET11a-CpGST construct did not yield a recombinant CpGST product. 
Generally, when no protein can be detected after expression trials, protein toxicity is most 
often thought to be the cause (Young et al., 2012). This occurs when the recombinant protein 
performs functions which can be harmful to the host cell either before or after induction. If 
these functions are disruptive to the homeostasis or proliferation of the host cell, either 
slower growth rate, low cell density or death will be observed. Though rare, this typically 
occurs in E. coli BL21 (DE3) cells and could be the reason as to why no expression occurred 
(Mierendorf et al., 2000, Saccardo et al., 2016). Alternatively, the lack of expression is often 
seen when the metabolic activity of the host is not favourable for target protein, stressing the 
expression system so much so that insoluble proteins are produced in the form of aggregates 
80 
 
(Mierendorf et al., 2000). This often leads to the denaturation of the target protein if not 
packaged in inclusion bodies. 
In instances where protein production is not successful even after various optimization 
attempts, alternative vectors, promoters, cell expression lines and even co-expression with 
chaperones through fusion tags are often used. In the case of this study, pCOLD vectors were 
used to aid in successful protein expression due to other avenues not being available or 
affordable. The existence of cold shock proteins (Csp) such as CspA within these vectors allows 
for high protein yield after their induction at lower temperatures (Qing et al., 2004). Their 
function as RNA chaperones allowed for regulated transcription and translation at lower rates 
resulting in successful production of recombinant CpGST (Jiang et al., 1997, Saini et al., 2014). 
Although the protein produced was insoluble, the size of the protein expressed in the pCOLD1 
vector was ~ 50 kDa as anticipated from the theoretical size. Although pCOLD1 allowed for 
the recombinant expression of CpGST, recovering a protein from inclusion bodies can be often 
be cumbersome as it could result in a denatured, inactive protein product after 
resolubilization (Georgiou and Valax, 1996). Retrieving an insoluble protein from the 
aggregated state also reduces the recovered yield one has to work with for characterization 
purposes (Wingfield, 2015). Additionally the purification steps taken to carefully extract and 
purify the protein of interest are rather long and do not guarantee an enzymatically active 
protein product after resolubilization (Trimpin, 2009). Another disadvantage when working 
with proteins in inclusion bodies is the steps, material and cost of denaturing and unfolding 
the protein for the purposes of refolding in the correct conformation or partially folding the 
protein can often times be ineffective and time wasting (Wingfield, 2015). The further analysis 
and purification of soluble, correctly folded protein is often preferred. 
To avoid the previously mentioned complications experienced with insoluble proteins, a 
pCOLDTF vector was used which utilizes the trigger factor chaperone to assist in the 
production of a soluble protein. The trigger factor itself assists and protects the nascent chain 
with long hydrophobic stretches during protein production and the beginning folding stages 
whilst also fast tracking peptidylpropyl cis-trans isomerization (Saini et al., 2014). As the 
recombinant protein is made, the chaperones are constantly recruited to shield the 
polypeptides on the ribosome through productive de novo folding all to prevent degradation 
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and aggregation (Hoffmann et al., 2006). This lead to the soluble production of CpGST with 
the chaperone attached in Figure 3.4b.  
The over-expressed protein was then easily purified from the other bacterial proteins though 
affinity chromatography. This exploited the affinity that the his-tagged proteins have on the 
Ni2+ ions in the column. Most of the bacterial proteins either flowed through the column or 
were washed away with low concentrations of imidazole as non specific binding was observed 
at imidazole concentration lower than 250 mM (Bornhorst and Falke, 2000). This occurrence 
is anticipated as at least 2% of all protein residues are histidine. Furthermore few proteins 
can have multiple adjacent histidine residues which could co-elute with the CpGST and be  
considered as contamination (Schmitt et al., 1993). To displace the proteins with stronger 
affinity to Ni2+, higher concentrations were used resulting in a protein with fewer conaminants 
being eluted at 250 mM imidazole. The protein of interest was also eluted at lower 
concentrations of imidazole indicating various affinities the protein has to the Ni2+. 
The protein eluted at 250 mM imidazole in the IMAC column was then concentrated and 
subjected to SEC to separate CpGST from contaminants while confirming the size obtained 
from the SDS-PAGE gels. The two peaks obtained from the SEC pointed to the separation of 
two proteins of different sizes. Due to the fact that the gel filtration column was run under 
native conditions, the protein sizes expected for GSTs which typically exist as dimers would 
be doubled. As anticipated the first peak containing the protein of interest was double the 
GST monomer size. This could be due to dimerization that GSTs typically undergo in their 
native state (Sheehan et al., 2001). Another explanation for the oligomerization is presence 
of free GSH and other xenobiotic compounds within the expression environment that 
activates the conjugation of GSH to the foreign compound, leaving the enzyme in an active 
dimer form (Tripathi, 2007). This would not be reflected in the SDS page gel because of the 
denaturing effects of the buffers used and the heating of the protein samples in gel sample 
preparation (Laemmli, 1970).  
3.6. Conclusion 
This is the first report of on CpGST2 expression and purification. In this study, CpGST2 protein 
was not successfully expressed using the pET 11a vector and was expressed as an insoluble 
protein in pCOLD1 vector. Using pCOLDTF expression vector, CpGST2 was successfully 
expressed in a soluble form as 102 kDa protein.  This protein was tagged to the trigger factor 
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chaperone which assisted the CpGST2 protein to fold into its native conformation. Future 
studies would thereafter encompass the removal of the trigger factor so to explore 
crystallization studies and simultaneously characterize the GST protein to determine Gamma 
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4.1. Closing Remarks 
Cryptosporidiosis is classified as a neglected gastrointestinal disease with worldwide impact 
on immune compromised children and adults. However, as mentioned there is only one U.S. 
Food and Drug Administration (FDA) approved drug available for its treatment (Certad et al., 
2017, Shirley et al., 2012,). This drug is called nitazoxanide and is ineffective in immune 
compromised patients. In addition, there are also no vaccines available or efficient 
preventative strategies put in place to resolve cryptosporidiosis. The few preventative 
measures taken to reduce the impact the disease has on the largely disadvantaged 
communities are adequate access to water supplies, improved sanitation and appropriate 
health education (Feasey et al., 2009). These attempts however are unfortunately short term 
and do not adequately reduce the global burden cryptosporidiosis causes.  The absence of 
effective non-discriminatory treatments or vaccines for cryptosporidiosis highlights the 
urgency for the development of therapeutic intervention from this disease.  
Glutathione transferases which are phase II detoxification enzymes have been identified as a 
therapeutic target in Cryptosporidium species (Mauzy et al., 2012) . In other apicomplexan 
species, detoxification proteins have been identified and exploited successfully as a 
therapeutic target (Fritz-Wolf et al., 2003). These proteins have been scarcely researched in 
Cryptosporidium species with their molecular and biophysical characteristics being unknown. 
The current study took to bridge that knowledge gap taking advantage of bioinformatics tools 
and molecular techniques such as protein expression and purification.  
Each of the 15 Cryptosporidium species mined possessed three GST genes, of which two thirds 
were full length proteins. The cellular localization of these full length proteins were 
determined to be cytosolic in nature as opposed to being mitochondrial or membrane-
associated proteins involved in eicosanoid and gluthatione metabolism. Cytosolic GSTs are 
said to be the most ancient within this group (Jemth and Mannervik, 1997). When 
determining the similarities found within the Cryptosporidium GSTs phylogenetically, the 
phylogenetic tree showed the GST separated into three different clades. The GSTs within each 
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clade had the following: i) GSTs with similar amino acid lengths. ii) One Cryptosporidium 
species within each clade, with the exception of group 3. Not a single clade had two proteins 
from one species. iii) The GSTs within each clade shared 42-100 % amino acid identity whilst 
the percentage identity between each clade dropped to as low as 10%.  These divisions 
pointed to the notion of the Cryptosporidium GSTs not belonging to the same class. Based on 
the fact that GSTs within each class share secondary structural traits, immunological cross 
reactivity and sensitivity to inhibitors, determining the class that the Cryptosporidium GST 
belonged to might share further insight into these traits. However, the phylogenetic tree built 
with pre-existing GSTs showed the separation of the GST clades, highlighting the novelty of 
the Cryptosporidium GSTs. These results concluded that the separate clades formed three 
new classes of GSTs which were denoted Vega, Gamma and Psi class GSTs. Similarly, the 
Plasmodium falciparum GST which could not be assigned to any previously known classes, 
and thus designated its own class (Fritz-Wolf et al., 2003). 
This was an exciting discovery, however to further investigate the structural elements the 
classes possessed, homology models were built. This would additionally reveal any class 
specific variations the novel GSTs had from the conical GST's. One GST from each class was 
chosen to be a class representative for structural features. The modelled GSTs all had the 
highly conserved proline residue that forms parts of the cis-Pro loop (Allocati et al., 1999). 
This is responsible for connecting the N- and C-terminal regions to maintain structural 
integrity. The active side tyrosine which is also usually conserved in GSTs was not found in the 
expected position in the Vega and Psi class GSTs.  The Vega class GST was found to have an 
atypical N-terminal domain with only two beta sheets instead of the expected four found in 
most GST proteins. The Gamma and Psi class GSTs had the typical thioredoxin like fold with 
the N-terminal domain containing 4 𝛽 sheets and 3 𝛼 helices. The C-terminal domain for all 
three Cryptosporidium GST classes was all helical with much variation in sequence identity 
and secondary structure conformation to allow for the conjugation of various xenobiotic 
compounds (Frova, 2006). 
To obtain further physiological information on Cryptosporidium GSTs, the least novel GST was 
expressed and purified. It was anticipated that the Gamma class GST had an open reading 
frame of which comprised of 1299 bp encoding a protein of 429 amino acids with a calculated 
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molecular size of 49 kDa. This size difference seen between the gamma class GST and pre-
existing GST was attributable to the N-terminal and C-terminal extensions seen in Figure 4.1.   
          
Figure 4.1: Schematic diagram of the full length CpGST with the InterPro and Pfam confirmed GST domains 
and the N- and C-terminal extensions. 
The presence of the Gamma class Cryptosporidium parvum GST2 (CpGST) gene was 
successfully confirmed in the expression vectors selected for this study using PCR and 
restriction digest. Thereafter the three gene constructs were screened to determine the most 
efficient vector for the recombinant expression of CpGST. The pET 11 was not successful in 
the expression of the recombinant CpGST possibly due to protein toxicity (Young et al., 2012). 
The pCOLD1 vector was also unsatisfactory as a protein of the expected size (~ 50 kDa) was 
expressed in insoluble form. It is worth noting that this size corresponds to the theoretical 49 
kDa value previously mentioned. This is double the size of traditional cytosolic GSTs which 
range from 24-29 kDa (Sheehan et al., 2001). This was yet another indication of the novelty 
of this new GST class. The pCOLDTF vector was then used which exploited the cold shock 
protein and trigger factor molecular chaperone which slowed protein translation in low 
temperatures and facilitated protein formation in the correct conformation (Qing et al., 2004, 
Saini et al., 2014). This resulted in a ~ 100 kDa recombinant protein due to expression of 
CpGST tagged with trigger factor which is 47 kDa.  
The recombinant CpGST was purified successfully to homogeneity using two chromatographic 
techniques namely affinity chromatography and size exclusion chromatography. The affinity 
chromatography eluent was semi pure and thus further purified using size exclusion 
chromatography. The native conditions in which this purification step was performed allowed 
for the protein to be eluted as a dimer. The protein homogenous protein was eluted at double 
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CHAPTER 2 SUPPLEMENTARY DATASET 
Table S1: Information on different glutathione transferase classes found in organisms.  
GST Class Cellular 
localization 
General Information Reference 
Alpha  Cytosol Found in a broad range of species. Involved in the biosynthesis of sex steroids and keto-steroid isomerase activity. Deponte and Becker, 2005 
Beta Cytosol Typically found in bacterial species. Known for conjugating antibiotics, assisting in antibiotic resistance to other organisms. Shehu et al., 2019 
CLIC Cytosol Found in a broad range of species. Enter intracellular membranes and form membrane channels. Board and Menon, 2013 
Delta and 
Epsilon 
Cytosol Typically found in insects. Thought to contribute to detoxication or antioxidative stress during development. Delta GSTs are also involved in 
oogenesis.  
Scian et al., 2015, 
Udomsinprasert et al., 2005 
Kappa Mitochondrial To date, found in primates and mice. Oligomerization of adiponectin. Robinson et al., 2004 
Lambda Cytosol Typically found in plants. Function is not yet known as they have no detectable GSH-conjugating activity. Chronopoulou et al., 2017 
MAPEG Microsomal Found in a broad range of species. Involved in production of leukotrienes and prostaglandin E and are mediators of inflammation.  Akil et al., 2012 
Mu Cytosol Found in a broad range of species. Forms inhibitory complexes with ASK1, another member of the MAP kinase pathway. Torres-Rivera and Landa, 
2008 
Omega Cytosol Found in a broad range of species. Catalyzes reduction and thioltransferase reactions.  Wu and Dong, 2012 
Phi Cytosol Typically found in plants. Inhibits oxidative damage through the removal of endogenous cytotoxic hydroperoxides. Munyampundu et al., 2016 
Pi Cytosol Found in a broad range of species. Regulates JNK and TRAF signaling and catalyzes the S-glutathionylation reactions. Prade et al., 1997 
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Sigma Cytosol Found in a broad range of species. Involved in prostaglandin synthesis by isomerization of PGH2 – PGD2. Board and Menon, 2013 
Tau Cytosol Typically found in plants. 
Involved in reactive oxygen species scavenging and improves plant chilling tolerance 
Yang et al., 2016 
Theta Cytosol Found in a broad range of species. 
Has dichloromethane dehalogenase activity for the degradation of dichloromethane to obtain energy 
Shehu et al., 2019 
Xi Cytosol Typically found in bacteria, fungi, and archaea. 
Aids in extreme haloalkaphilic conditions. 
Di Matteo et al., 2019 
Zeta Cytosol Found in a broad range of species. Involved in isomerization of maleyacetoacetate to fumaracetoacetate in tyrosine degradation pathway and 
biotransformation of dichloroacetic acid to glyoxylate 
Board et al., 1997 
Symbol: *, Based on in silico prediction. Abbreviations: GSH, Glutathione; ASK1, Apoptosis signal-regulated kinase 1; MAP, Mitogen activated protein; JNK, c-Jun N-Terminal 
Kinase; TRAF, Tumor necrosis factor receptor (TNF)-associated factor; PGH2, Prostaglandin H2; PGD2, Prostaglandin D2
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Group 1 (Vega (ϑ)) 
 
 
C. andersoni 30847 GST1.                        MNDSNYPYSVKSPLKLIYFACRGSCDVIRLLLNDKCIPY--------------------- 39 
C. muris RN66 GST1                              -------------------------------------MI--------------------- 2 
C. baileyi strain TAMU-09Q1 GST1                ------------------------------------------------------------ 0 
C. ubiquitum_39726 GST1                         ---MEYIGSLDNPLRLIYFSCRGTCDAIRLLLVDQEIPYE-------------------- 37 
Cryptosporidium sp. chipmunk LX-2015 GST1      -----------------ILYFRGTCDVIRLLLVDQEIPYEGKLKRYCQLIIYTVFSSGIQ 43 
C. viatorum isolate UKVIA1 GST1                 -----------------------------------ILKY--------------------- 4 
C. meleagridis_UKMEL1 GST1                      ---MEYIGSLDNPLRLIYFSCRGTCDVIRLLLVDQEIPY--------------------- 36 
C. tyzzeri_UGA55 GST1                           -----------------------------------MIEY--------------------- 4 
C. parvum_Iowa II GST1                          -----------------------------------MIEY--------------------- 4 
C. hominis_TU502_2012 GST1                      -----------------------------------MIEY--------------------- 4 
C. hominis_30976 GST1                           -----------------------------------MIEY--------------------- 4 
C. hominis TU502 GST1                           -----------------------------------MIEY--------------------- 4 
C. hominis_UdeA01 GST1                          -----------------------------------MIEY--------------------- 4 
                                                                                  
 
C. andersoni 30847 GST1                         -----EEHNIQGKDFLQPEFQNVLLESDNFPILPYLSDPNSEMELTGSLTILRYLGRKCN 94 
C. muris RN66 GST1                              -----NVFHMKGKDFLQSEFQNVLLESDNFPILPYLSDPNSEIELTGSLTILRYLGRKCN 57 
C. baileyi strain TAMU-09Q1 GST1                ------EHNISGKDFLQEEFQQVLIESGNFPMLPYLSDSNNEVELTGSFTILRYLGEKCK 54 
C. ubiquitum_39726 GST1                         -----------GKDFLQPEFQHVLAESGNFPMLPYLSDSNNEVELTGSFTILRYLADKCK 86 
Cryptosporidium sp. chipmunk LX-2015 GST1       KFLNILEHNISGKDFLQPEFQQVLVESGNFPMLPYLSDSNNEVELTGSFTILRYLADKCK 103 
C. viatorum isolate UKVIA1 GST1                 -----IEHNISGKDFLQPEFQQVLVESGNFPMLPYLSDSNNEVELTGSFTILRYLADKCK 59 
C. meleagridis_UKMEL1 GST1                      -----EEHNISGKDFLQPEFQQVLLESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 91 
C. tyzzeri_UGA55 GST1                           -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 59 
C. parvum_Iowa II GST1                          -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYLSDSNNEVELTGSFTILRYLADKCK 59 
C. hominis_TU502_2012 GST1                      -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 59 
C. hominis_30976 GST1                           -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 59 
C. hominis TU502 GST1                           -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 59 
C. hominis_UdeA01 GST1                          -----LEHNISGKDFLQPEFQQVLVESGNFPMLPYFSDSNNEVELTGSFTILRYLADKCK 59 
                                                           ****** ***:** **.***:***:** *.*:*****:******. **: 
 
C. andersoni 30847 GST1                         LMGNNYEDELQIENWLEYLQLVLNILWEFDSNSDNFNNIQKNKKRGQFLLENLHPMLHNI 154 
C. muris RN66 GST1                              LMGNNYEDELQIENWFEYLQLVLNILWEFDSNLDSFNNIQKNKKRGQFLLENLHPMLHNI 117 
C. baileyi strain TAMU-09Q1 GST1                LMGNNVTERNKIENWLEFLQSLLHSIWDFENNITNYTESQKKKRKSQFLLENLHPMLRSI 114 
C. ubiquitum_39726 GST1                         LMGNNSEERNRVENWLEFLQSLLHSVWDFENISENYTGVQQTKKKSKFLLDTLHPMLKCI 146 
Cryptosporidium sp. chipmunk LX-2015 GST1       LMGKSPEERNKIENWLEYLQSLLHSVWDFENRSDNYTGVQQTKKRSQFLLETLHPMLKCI 163 
C. viatorum isolate UKVIA1 GST1                 LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQHTKKKSQFLLETLHPMLKCI 119 
C. meleagridis_UKMEL1 GST1                      LMGKSPEERNKIENWLEYLQSLLHSLWDFENMSDNYTGIQQTKKKRQFLLETLHPMLKCI 151 
C. tyzzeri_UGA55 GST1                           LMGKSPEERNKVENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
C. parvum_Iowa II GST1                          LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
C. hominis_TU502_2012 GST1                      LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
C. hominis_30976 GST1                           LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
C. hominis TU502 GST1                           LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
C. hominis_UdeA01 GST1                          LMGKSPEERNKIENWLEYLQSLLHSVWDFENMSDNYTGIQQAKKKSQFLLETLHPMLKCI 119 
                                                ***:.  :. ::***:*:** :*: :*:*:.   .:.  *: *:: :***:.*****: * 
 
C. andersoni 30847 GST1                         QVRLDNGKKWIMEEYSVADIMLYTVVSAIIRSWGYEILQPYDK----------------- 197 
C. muris RN66 GST1                              QARLDNGKKWILEEYSVADIMLYTVVSAIIRSWGYEILQPYDK----------------- 160 
C. baileyi strain TAMU-09Q1 GST1                NDKIESN-LWALNDYSIIDIVLYSTISVVIKLWSIDLLKPYEK----------------- 156 
C. ubiquitum_39726 GST1                         DDKIEQG-FWALESYSVVDIVLYSTISVVIRSWGSDLLKPYIRILSHKKNMEKLRKQIDS 205 
Cryptosporidium sp. chipmunk LX-2015 GST1       DEKIEHG-VWVLDSYSVVDIVLYSAISVIIRSWGGDLLKPYTR----------------- 205 
C. viatorum isolate UKVIA1 GST1                 DEKIEQG-VWALDSYSVVDVVLYSAISVVIRSWGIDLLKPYIK----------------- 161 
C. meleagridis_UKMEL1 GST1                      DEKIEQG-VWALESYSVVDIVLYSAISVVIRSWGSDLLKPYIR----------------- 193 
C. tyzzeri_UGA55 GST1                           DEKIEQG-VWALEYYSVVDIVLYSAISVIIRSWGSDLLKPYIRILTHKKNMEKLRKQIDS 178 
C. parvum_Iowa II GST1                          DEKIEQG-IWALESYSVVDIVLYSAISVIIRSWGSDLLKPYIRILTHKKNMEKLRKQIDS 178 
C. hominis_TU502_2012 GST1                      DEKIEQG-VWALESYSVVDIVLYSAISVIIRSWGSDLLKPYIRILTHKKNMEKLRKQIDS 178 
C. hominis_30976 GST1                           DEKIEQG-VWALESYSVVDIVLYSAISVIIRSWGSDLLKPYIRILTHKKNMEKLRKQIDS 178 
C. hominis TU502 GST1                           DEKIEQG-VWALESYSVVDIVLYSAISVIIRSWGSDLLKPYIR----------------- 161 
C. hominis_UdeA01 GST1                          DEKIEQG-VWALESYSVVDIVLYSAISVIIRSWGSDLLKPYIR----------------- 161 
                                                : ::: .  * :: **: *::**:.:*.:*: *. ::*:** :                  
 
C. andersoni 30847 GST1                         -------- 197 
C. muris RN66 GST1                              -------- 160 
C. baileyi strain TAMU-09Q1 GST1                -------- 156 
C. ubiquitum_39726 GST1                         FKDDPRRF 213 
Cryptosporidium sp. chipmunk LX-2015 GST1       -------- 205 
C. viatorum isolate UKVIA1 GST1                 -------- 161 
C. meleagridis_UKMEL1 GST1                      -------- 193 
C. tyzzeri_UGA55 GST1                           FKDDPRRF 186 
C. parvum_Iowa II GST1                          FKDDPRRF 186 
C. hominis_TU502_2012 GST1                      FKDDPRRF 186 
C. hominis_30976 GST1                           FKDDPRRF 186 
C. hominis TU502 GST1                           -------- 161 
C. hominis_UdeA01 GST1                          -------- 161 
                              
 
Group 2 (Gamma (γ)) 
 
 
C. andersoni 30847 GST2              MIGVNSSISTGVASFSRDLSSLPGTSFIP-----AKAGSPQKSPSNLYGVIQAPRATSIR 55 
C. ubiquitum_39726 GST2              MNNIGAGTTASPKNIATKVSSELNEIYSPKMSNLIRSNAPCRL---TSNRVMIPSKSTYR 57 
C. viatorum isolate UKVIA1 GST2      MNNIEASTTASPKIIAAKVSSELNEIYSPKMSKLVRNNIPCRL---TTNRVMAPSRSTYR 57 
C. meleagridis_UKMEL1 GST2           MNSKETSTISSPKIIASKISSESSEIYSPKISTLTRNSIPCRL---TSNRVMASSKSTYR 57 
C. hominis_TU502_2012 GST2           MNNKETSTIPSPKTIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. hominis_UdeA01 GST2               MNNKETSTIPSPKTIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. hominis_30976 GST2                MNNKETSTIPSPKTIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. hominis_TU502 GST2                MNNKETSTIPSPKTIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. parvum_Iowa II GST2               MNNKETSTIPSPNIIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. tyzzeri_UGA55 GST2                MNNKETSTIPSPKIIASKISSELSEIYSPKMSTLVRNNIPCRL---TSNRVMAPSKSTYR 57 
C. baileyi strain TAMU-09Q1 GST2     ---------------------------------PMRSNVPCRL---TNNRIMMPSKSTVK 24 
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C. ryanae isolate 45019 GST2         ---------------------------------MSKTIIPFRL---TSNRIMIPSRSAVR 24 
C. bovis isolate 42482 GST2          ---------------------------------------------------MIPSRSAVR 9 
                                                                                             :: : 
 
C. andersoni 30847 GST2              VMLPVRDIGDLTVVTYEHQAFVGCGGSLRFFLLGKQVKHKFINVPVDKDNPIPDYIESSK 115 
C. ubiquitum_39726 GST2              VILPVRDIGDLSVITYEHEIYLGNGGSLRFFLLGKQVRHRFINVPLDEENPIPSYIDSDK 117 
C. viatorum isolate UKVIA1 GST2      VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEEDPIPSYIDPNK 117 
C. meleagridis_UKMEL1 GST2           VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. hominis_TU502_2012 GST2           VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. hominis_UdeA01 GST2               VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. hominis_30976 GST2                VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. hominis_TU502 GST2                VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. parvum_Iowa II GST2               VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. tyzzeri_UGA55 GST2                VILPVRDIGDLSVITYEHEVYVGNGGSLRFFLLGKQVRHRFINVHLDEESPIPSYIDPNK 117 
C. baileyi strain TAMU-09Q1 GST2     VVLPVRDIGELSVVTYEHDIFVGNGGSIRFFLLGKQVRHRFINVPLDEENPIPSFIDSSR 84 
C. ryanae isolate 45019 GST2         VVLPVRDIGELTVITFEHDIFVGNGGSIRFFLLGKQVRHRFVNVPLDEEKPIPSYIDSSR 84 
C. bovis isolate 42482 GST2          VVLPVRDIGELTVVTFEHNVFVGNGGSIRFFLLGKQVRHRFVNVPLDEEKPIPSYIDSSR 69 
                                     *:*******:*:*:*:**: ::* ***:*********:*:*:** :*::.***.:*: .: 
 
C. andersoni 30847 GST2              VPLGELPIIKLGDLVIFDEIPCLRFLAKKLGEYGRNYYIDFVIDDVVMRCNRWRDILMDL 175 
C. ubiquitum_39726 GST2              VPLGDLPIVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDVLMDL 177 
C. viatorum isolate UKVIA1 GST2      VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSRWRDILMEL 177 
C. meleagridis_UKMEL1 GST2           VPLGDLPIVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. hominis_TU502_2012 GST2           VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. hominis_UdeA01 GST2               VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. hominis_30976 GST2                VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. hominis_TU502 GST2                VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. parvum_Iowa II GST2               VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. tyzzeri_UGA55 GST2                VPLGDLPVVKLGDLVIFDEIPCLRYLAKKLGEYGRNYYIDFVIDDVIFRCSKWRDILMEL 177 
C. baileyi strain TAMU-09Q1 GST2     VPLGDLPIIKLGDLVLFDEIPCLRYLAKKLGEYGRNYYIDFVIDDIILRCSRWRDVIMEI 144 
C. ryanae isolate 45019 GST2         VPLGDLPIIKLGDLVLFDEIPCLRYLAKKLGEYGRNYYVDFVIDDIILRCSRWRDIIMEL 144 
C. bovis isolate 42482 GST2          VPLGDLPIVKLGDLVLFDEIPCLRYLAKKLGEYGRNYYVDFIIDDIILRCSRWRDIIMEL 129 
                                     ****:**::******:********:*************:**:***:::**.:***::*:: 
 
C. andersoni 30847 GST2              ILSSNNCMLAASTNLDKSEAPYSLNNSENSGGSAISSLEGYKQLREQLYTEFEVLITSIG 235 
C. ubiquitum_39726 GST2              ISRNYSELSNGN---------------INTNKELESSISNYKLLREQLYCEFETLIASIG 222 
C. viatorum isolate UKVIA1 GST2      ISKSHKEFLNSN---------------INANNELEKSISNYKLLREQLYCEFETLIASIG 222 
C. meleagridis_UKMEL1 GST2           ILKSHKEFLIND---------------INTNKELERLISNYKLLREQLYCEFETLISSIG 222 
C. hominis_TU502_2012 GST2           ISKSHKEFLIND---------------INAKKELERSISNYKLLREQLYCEFETLISTIG 222 
C. hominis_UdeA01 GST2               ISKSHKEFLIND---------------INAKKELERSISNYKLLREQLYCEFETLISTIG 222 
C. hominis_30976 GST2                ISKSHKEFLIND---------------INAKKELERSISNYKLLREQLYCEFETLISTIG 222 
C. hominis_TU502 GST2                ISKSHKEFLIND---------------INAKKELERSISNYKLLREQLYCEFETLISTIG 222 
C. parvum_Iowa II GST2               ISKSRKEFLIND---------------INANKELERSTSNYKLLREQLYCEFETLILSIG 222 
C. tyzzeri_UGA55 GST2                ISKSRKEFLINE---------------INANKELERSISNYKLLREQLYCEFETLISSIG 222 
C. baileyi strain TAMU-09Q1 GST2     ISKGAAIVPNKN---------------S-V-QDHINSLSNYKVLREKFYSEFETLITCIG 187 
C. ryanae isolate 45019 GST2         IPGSNTGVSAKS---------------Y-I--EETNSLSNYKLLREQFYYEFETLITCIG 186 
C. bovis isolate 42482 GST2          ITENNTGSYSKN---------------H-VKGEEINPISNYKLLREQFYYEFETLITCIG 173 
                                     *  .       .                    .     ..** ***::* ***.**  ** 
 
C. andersoni 30847 GST2              EKEGSYIADKDKPMICDFALFSVLFDDINLSDISPDSMFQRIELLPDNCLIHQFPRLKSL 295 
C. ubiquitum_39726 GST2              DK-GPFIAEKNKPMICDFILFSILFDDISLIEFSETEKFNRVTLLPERSIIHKFPRLKML 281 
C. viatorum isolate UKVIA1 GST2      DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNETEKFNRMKLLPEESIIHKFPRLKML 281 
C. meleagridis_UKMEL1 GST2           DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKLNRTSLLPEESIIHKFPRLKML 281 
C. hominis_TU502_2012 GST2           DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKINRTSLLPEESLIHKFPRLKML 281 
C. hominis_UdeA01 GST2               DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKINRTSLLPEESLIHKFPRLKML 281 
C. hominis_30976 GST2                DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKFNRTSLLPEESLIHKFPRLKML 281 
C. hominis_TU502 GST2                DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKFNRTSLLPEESLIHKFPRLKML 281 
C. parvum_Iowa II GST2               DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKFNRTSLLPEESLIHKFPRLKML 281 
C. tyzzeri_UGA55 GST2                DK-GPFIAEKNKPMICDFILFSILFDDISLIEFNEGEKFNRTSLLPEESLIHKFPRLKML 281 
C. baileyi strain TAMU-09Q1 GST2     ER-GPFIADKNKAMICDFALFSILFDDVSLMEINEHDQLNRTVLLPENCIIHKFPRLKLL 246 
C. ryanae isolate 45019 GST2         DS-GIFIADSNRPMICDFILFSILFDDISLVEIDENNQFNRTTMIPENSIIHRFPRLKIL 245 
C. bovis isolate 42482 GST2          ES-GIFIADGNKPMICDFILFSILFDDISLVEIDDNNQFNRTAMLPENSIIHRFPRLKIL 232 
                                     :  * :**: :: ***** ***:****:.* ::.  . ::*  ::*:..:**:***** * 
 
C. andersoni 30847 GST2              FLVMSELPLVNQWIKGKYFIQSNIDKATNKDSNENAAASTFPLQSSIVGNQQPSHSLYSL 355 
C. ubiquitum_39726 GST2              FESVAILPLIDQWIKGKYFAIQIEGESSELVT---------PPTSLTTQDHG-------- 324 
C. viatorum isolate UKVIA1 GST2      FESVATLPLIDQWVKGKYFDIQIEGENSELLT---------PPASLSTQDYA-------- 324 
C. meleagridis_UKMEL1 GST2           FESVVMLPLIDQWVKGKYFSIQIEGESGELVT---------PPTSLSTQDHV-------- 324 
C. hominis_TU502_2012 GST2           FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDHV-------- 324 
C. hominis_UdeA01 GST2               FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDHV-------- 324 
C. hominis_30976 GST2                FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDHV-------- 324 
C. hominis_TU502 GST2                FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDHV-------- 324 
C. parvum_Iowa II GST2               FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDHV-------- 324 
C. tyzzeri_UGA55 GST2                FESVAVLPLIDQWVKGKYFSIQIEGESGELVT---------PPASLSTQDYV-------- 324 
C. baileyi strain TAMU-09Q1 GST2     FESIAALPLIDQWIKGKYFIIEVENDNNDQVN---------LLTSNLLQESN-------- 289 
C. ryanae isolate 45019 GST2         FESISSLPLIEQWIKGKYFLVNIESESNIGDL---------ITQKNSFPIM--------- 287 
C. bovis isolate 42482 GST2          FESISSLPLIEQWIKGKYFIVNVEGEINAKDL---------TAQKNSFPIM--------- 274 
                                     *  :  ***::**:*****  .  ..                  .                
 
C. andersoni 30847 GST2              GAGNGIASPGVFSIYQSSHPLNPPIPRFQYPMIPYMPNQGLVQASAGVRFAFPGAGLPIN 415 
C. ubiquitum_39726 GST2              --------TNF-VVGTNSFIGCPNSFGYQPPVFQQLPNQLFAHVNAGIRFFPQNMAMPIN 375 
C. viatorum isolate UKVIA1 GST2      --------TNF-VSGSNSFNGYQHSLGYQPPVFQQLPNQIFAHVNAGVRFFPQKMSLPIN 375 
C. meleagridis_UKMEL1 GST2           --------RNS-VLGSNSFNWYQHSFGYQPPVPQQLPNQIFTHVSAGVRFFPQKVPLPIN 375 
C. hominis_TU502_2012 GST2           --------KNS-VLGSNSFNVYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
C. hominis_UdeA01 GST2               --------KNS-VLGSNSFNVYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
C. hominis_30976 GST2                --------KNS-VLGSNSFNVYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
C. hominis_TU502 GST2                --------KNS-VLGSNSFNVYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
C. parvum_Iowa II GST2               --------KNS-VLGSNSFNAYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
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C. tyzzeri_UGA55 GST2                --------KSS-VLGSNSFNVYQHSFGYQPPVLQQLPNQIFTHVNAGVRFFPQKMSLPIN 375 
C. baileyi strain TAMU-09Q1 GST2     --------QSLINGYNNAFVNYPPMLRFQPFP-FQHGNQIFAQANAGVRFFSPSTMPTNN 340 
C. ryanae isolate 45019 GST2         ---------EHTNHFFKKEVGNNQSSRFLPPIFQQPPNQIFGQATAGIRFLHQPINHINN 338 
C. bovis isolate 42482 GST2          ---------EHSNNFYRQDLEHSPLPRFSPPIFQQFPGQVFAQTTAGIRFVPQPFNHMNS 325 
                                                                :         .* : :..**:**         . 
 
C. andersoni 30847 GST2              NQQIPVIQANSSFINPHFAPQLNPSLIHPF--PIYQTNLGSP-CNRMSPSQSFT--- 466 
C. ubiquitum_39726 GST2              QPIFS---PNNSFVSQPITNYY-PFLNNQIQNHGYLGGVSSPFVQRISPSQSFKLKF 428 
C. viatorum isolate UKVIA1 GST2      QPIFS---PNNSFISQPIANYHHHFLNNQIQSHGYLGGVSSPFIQKASPR-SFKLKF 428 
C. meleagridis_UKMEL1 GST2           P-TFP---TNNSFISQPITNNYHHFLNSQIQDHRYLGRASSPFIQRVSPSQSFKLEF 428 
C. hominis_TU502_2012 GST2           P-IFP---TNNSFISQPITNNYHHFLNSQVQGHRYLGGVSSPFMQRVSPSQSFKLEF 428 
C. hominis_UdeA01 GST2               P-IFP---TNNSFISQPITNNYHHFLNSQVQGHRYLGGVSSPFMQRVSPSQSFKLEF 428 
C. hominis_30976 GST2                P-IFP---TNNSFISQPITNNYHHFLNSQVQGHRYLGGVSSPFMQRVSPSQSFKLEF 428 
C. hominis_TU502 GST2                P-IFP---TNNSFISQPITNNYHHFLNSQVQGHRYLGGVSSPFMQRVSPSQSFKLEF 428 
C. parvum_Iowa II GST2               PSIFP---TNNSFISQPITNNYHHFFNSQVQGHRYLGGVSSPFIQRVSPSQSFKLEF 429 
C. tyzzeri_UGA55 GST2                QSIFP---TNNSFISQPITNNYHHFLNRQVQGHRYLGGVSSPFIQRVSPSQSFKLEF 429 
C. baileyi strain TAMU-09Q1 GST2     YPIIP---SSNSFISHSFVNYHPHLWSNQFMGNYCSSGFSSPVQQKMSPAQSF---- 390 
C. ryanae isolate 45019 GST2         LHRIS---PSNSFGLQ-PQFHAPQAWMHQINGNCYFNNI------------------ 373 
C. bovis isolate 42482 GST2          FHRIS---PSNSFNLQ-PRSYAPQTWMHQINGSCYFNNITSPMQFRASPNPSFRM-- 376 




Group 3 (Psi class) 
 
C. baileyi strain TAMU-09Q1 GST3      -------------------------------PMYLYTTKELDNTQILRSLMVVSSLPFYE   29 
C. meleagridis_UKMEL1 GST3            MKSISLLASVFAFLALFSTSVESVKAKARIIPITFYSTKELDSNHLIRTVLVYSGLAFAE   60 
C. ryanae isolate 45019 GST3          ---------------------------------MFYTSKTIDNSHLIRTLLVLSGIPFNE   27 
C. bovis isolate 42482 GST3           ---------------------------------MFYTSKTLDSTHLIRTLLILSSLPFNE   27 
                                                                        :*::* :*..:::*:::: *.: * * 
 
C. baileyi strain TAMU-09Q1 GST3      VRFTKDSEAKKFFFDKIKSLGYLTPSIPVLSDPETFNSYISTEEAISQYILLSYYKELYP   89 
C. meleagridis_UKMEL1 GST3            TRFKKDSESQAKLFKEITKSGFLQPSIPMISDTGKNVQYLSTDEAVLNYIILSYNKELFS   120 
C. ryanae isolate 45019 GST3          FRFKKNSPSLEEMFNSVVESGFLVPSIPMITDNEYSVKNISQEEAIIHYLILSYYPDLFP   87 
C. bovis isolate 42482 GST3           FRFKKNSSSMEEMFSSIIESGFLNPTIPMISDNEYSVRNLSQDEAIVHYLVLSYYGELFQ   87 
                                       **.*:* :   :*..: . *:* *:**:::*       :* :**: :*::***  :*:  
 
C. baileyi strain TAMU-09Q1 GST3      STISEYIYSIQAASLMTSYMKKLTNILSESITLPCTKILTLNDIKHLLNVLEKKRSESKS   149 
C. meleagridis_UKMEL1 GST3            KNLLLHTISIQLSSIARSYIKKTTKILDSSKTLTCSKLLTNENIHQTLKVLNDTFASTEH   180 
C. ryanae isolate 45019 GST3          KVISDYAISLQIGSAVRSYIQKVHKIIELSQKLVCEKLLTIDNINITLKLLDDKFIETGS   147 
C. bovis isolate 42482 GST3           KSISDHAISLQIGSTVRSYISKVSGLLELSESLKCEKLLEIENVNVTLRLVNDRFTDTEY   147 
                                      . :  :  *:* .*   **:.*   ::. * .* * *:*  ::::  *.:::.   .:   
 
C. baileyi strain TAMU-09Q1 GST3      KYFYGEKYTYIDVSLYNLILFIENVSPGCVIRRYPSLTKLAFEFSQIPQVLAYERSPHFL   209 
C. meleagridis_UKMEL1 GST3            KFLIGNKVSFNDLIAYNLILFIENVASGCVISNFKGLRELAFNISSIPQIAKFESSSYFM   240 
C. ryanae isolate 45019 GST3          RFYFGGRYSYFDASVYTLILFVENISSGCITSNYEGLKAFSKEFSSISQISKFEKSSYFL   207 
C. bovis isolate 42482 GST3           KFFYGGKYSYIDTVVYTLILFIENISNGCIISNFDGLRSFSKEFSSIPQISKFEKSSYFL   207 
                                      ::  * : :: *   *.****:**:: **:  .: .*  :: ::*.* *:  :* * :*: 
 
C. baileyi strain TAMU-09Q1 GST3      SLTIPGTRAFAKPINFVLMSKAFDTLS- 236 
C. meleagridis_UKMEL1 GST3            SLLVPGTHTFAQRINFAHSSPMFLSLTS 268 
C. ryanae isolate 45019 GST3          SLIVPGTTRFVKPIDFVSQAHES----- 230 
C. bovis isolate 42482 GST3           SLLIPGTKEFVKPIDFVTQS-------- 227 
                                      ** :***  *.: *:*.  :         
 
Figure S1: Multiple amino acid alignment of glutathione transferases (GSTs) from Cryptosporidium species. 
The conserved amino acids, active site tyrosine and the cis-proline are bold and underlined. The N-terminal 
region is highlighted in cyan, the C-terminal region is highlighted in green and the purple text indicates the 
overlapping region where the N- and C-terminal regions are shared. 





Table S2: Prediction of transmembrane helices in glutathione transferase (GST) proteins of Cryptosporidium species and GSTs belonging to different classes. Prediction of 
transmembrane helices in GSTs were carried out using TMHMM - 2.0 
C. andersoni 30847 GST1(cand_012830) len=197 ExpAA=2.35 First60=0.01 PredHel=0 Topology=o 
C. hominis TU502_2012 
GST1(ChTU502y2012_407g2365/Q18145.1) 
 
len=186 ExpAA=1.21 First60=0.00 PredHel=0 Topology=o 
C. hominis 30976 GST1(GY17_00002363) 
 
len=186 ExpAA=1.21 First60=0.00 PredHel=0 Topology=o 
C. hominis TU502 GST1(XP_667744.1) len=161 ExpAA=2.65 First60=0.00 PredHel=0 Topology=o 
C. hominis UdeA01 GST1(CUV07467.1) len=161 ExpAA=2.65 First60=0.00 PredHel=0 Topology=o 
C. meleagridis UKMEL1 GST1(CmeUKMEL1_03350) 
 
len=193 ExpAA=1.11 First60=0.01 PredHel=0 Topology=o 
C. parvum Iowa II GST1(cgd7_4780) len=186 ExpAA=1.48 First60=0.00 PredHel=0 Topology=o 
C. tyzzeri UGA55 GST1(CTYZ_00001095) len=186 ExpAA=3.20 First60=0.00 PredHel=0 Topology=o 
C. ubiquitum 39726 GST1(cubi_03151) 
 
len=213 ExpAA=0.57 First60=0.01 PredHel=0 Topology=o 
C. muris RN66 GST1(XP_002141168.1) 
 
len=160 ExpAA=1.78 First60=0.00 PredHel=0 Topology=o 
Cryptosporidium sp. chipmunk LX-2015 GST1 
(JXRN01000042.1) 
len=205  ExpAA=3.35  First60=0.15 PredHel=0  Topology=o 
C. viatorum isolate UKVIA1 
GST1(QZWW01000010.1) 
len=161 ExpAA=1.92 First60=0.00 PredHel=0 Topology=o 
C. baileyi strain TAMU-09Q1 GST1(JIBL01000090.1) 
 
len=156 ExpAA=2.50 First60=0.00 PredHel=0 Topology=o 
C. baileyi strain TAMU-09Q1 GST2(JIBL01000106.1) 
 
len=390 ExpAA=0.01 First60=0.01 PredHel=0 Topology=o 
C. viatorum isolate UKVIA1 
GST2(QZWW01000018.1) 
len=428 ExpAA=0.02 First60=0.00 PredHel=0 Topology=o 
C. ryanae isolate 45019 GST2(VHLK01000046.1) len=373 ExpAA=0.03 First60=0.01 PredHel=0 Topology=o 
C. andersoni 30847 GST2(cand_023790) len=466 ExpAA=0.03 First60=0.00 PredHel=0 Topology=o 
C. hominis TU502_2012 
GST2(ChTU502y2012_421g0615) 
 
len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. hominis 30976 GST2(GY17_00000733) len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
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C. hominis TU502 GST2(Chro.80347) len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. hominis UdeA01 GST2(CHUDEA8_2970) len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. meleagridis UKMEL1 GST2(CmeUKMEL1_14570) 
 
len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. parvum Iowa II GST2(cgd8_2970). len=429 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. tyzzeri UGA55 GST2(CTYZ_0000322) len=429 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. ubiquitum 39726 GST2(cubi_03523) len=428 ExpAA=0.01 First60=0.00 PredHel=0 Topology=o 
C. bovis isolate 42482 GST2(VHIT01000012.1) len=376 ExpAA=0.33 First60=0.27 PredHel=0 Topology=o 
C. meleagridis UKMEL1 GST3(CmeUKMEL1_05845) len=268 ExpAA=11.30 First60=9.03 PredHel=0 Topology=o 
C. baileyi strain TAMU-09Q1 GST3(JIBL01000138.1) len=236 ExpAA=0.49 First60=0.19 PredHel=0 Topology=o 
C. ryanae isolate 45019 GST3(VHLK01000056.1) len=230 ExpAA=0.76 First60=0.19 PredHel=0 Topology=o 
C. bovis isolate 42482 GST3(PRJNA545579) len=227 ExpAA=2.32 First60=0.19 PredHel=0 Topology=o 
 
Abbreviations: len, the length of the protein sequence; ExpAA, the expected number of amino acids in transmembrane helices; First60, The expected number of amino 
acids in transmembrane helices in the first 60 amino acids of the protein; PredHel, the number of predicted transmembrane helices by N-best; Topology, the topology 
predicted by N-best.  
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Table S3: Comparative analysis of transmembrane helices in eukaryotic glutathione transferase. Prediction of 
transmembrane helices in GSTs were carried out using TMHMM - 2.0. Abbreviation: PredHel, the number of 
predicted transmembrane helices.  
GST Class Location (experimental) Number of GSTs analyzed TMHMM 2.0 results 
Alpha  Cytosol 37 PredHel=0  
Beta Cytosol 6 PredHel=0 
CLIC Cytosol 30 PredHel=0 
Delta Cytosol 29 PredHel=0 
Epsilon Cytosol 22 PredHel=0 
Kappa Mitochondrial 5 PredHel=0 
Lambda Cytosol 18 PredHel=0 
MAPEG Microsomal 20 PredHel=1-4 
Mu Cytosol 27 PredHel=0 
Omega Cytosol 32 PredHel=0 
Phi Cytosol 23 PredHel=0 
Pi* Cytosol 33 PredHel=0  
Sigma Cytosol 27 PredHel=0 
Tau Cytosol 21 PredHel=0 
Theta Cytosol 28 PredHel=0 
Xi Cytosol 4 PredHel=0 
Zeta Cytosol 33 PredHel=0 















Table S4: Analysis of Cryptosporidium species glutathione transferases (GSTs) cellular localization using Bologna Unified Subcellular Component Annotator (BUSCA) web-
server.  All Cryptosporidium species GSTs predicated to be located in cytoplasm. The two GSTs transmembrane membrane helix scores are below the values (0.93 and 1 for 
transmembrane) that can be considered as membrane bound proteins GSTs. 
GST GO-id GO-term Score Alternative localization Features 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 




C:cytoplasm 1 - 
 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 























C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 


















C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 


















C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 










C:endomembrane system 0.84 GO:0005886 - C:plasma membrane (score=0.47) Transmembrane Alpha 
Helix 




C:cytoplasm 0.7 GO:0005634 - C:nucleus (score=0.3) 
 




C:extracellular space 1 - 
 

















C:cytoplasm 0.89 GO:0005634 - C:nucleus (score=0.11) 
 
Cryptosporidium sp. chipmunk 
LX-2015 GST1 (JXRN01000042.1) 
GO:000561
5 
C:extracellular space 1 - - 
















C:cytoplasm 1 - 
 





















Table S5: Information on template hits obtained from different databases for homology modeling of Cryptosporidium parvum GSTs 1 and 2 and Cryptosporidium 
meleagridis UKMEL1 GST3 (CmGST3). Yellow-shaded templates were found to be the best combination to generate good quality 3D models.    
C. parvum GST1 (CpGST1) hits 
 PDB-Chain % Identity Query Cover Resolution R-Value Free R-Value Work 
NCBI 4L5O-A 51 23 % 2.09 0.248 0.202 
3ISO-A 51 23 % 1.90 0.226 0.179 
2WRT-A 45 24 % 2.40 0.281 0.205 
1FHE-A 45 24 % 3.00 0.354 0.237 
5AN1-A 37 40 % 2.00 0.262 0.214 
1YQ1-A 28 59 % 3.00 0.297 0.224 
PHYRE 1B8X-A 27 98 % 2.70 0.310 0.209 
5AN1-A 23 98 % 2.00 0.262 0.214 
1BG5-A 27 98 % 2.60 0.359 0.193 
1GTU-B 22 98 % 2.68 0.245 0.211 
1UA5-A 25 98 % 2.50 0.221 0.169 
1C72-A 21 98 % 2.80 0.190 0.190 
1VF1-A 20 98 % 1.77 0.217 0.192 
4Q5Q-A 20 98 % 1.93 0.227 0.180 
3C8E-B 19 96 % 2.71 0.181 0.182 
4MZW-A 19 97 % 1.92 0.194 0.152 
1GUM-A 18 98 % 3.00 0.270 0.253 
5H5L-A 18 98 % 2.00 0.238 0.173 
i-TASSER 3VPQ-A 26 94 % 1.70 0.227 0.188 
4Q5F-A 22 94 % 2.45 0.239 0.188 
1M0U-A 25 93 % 1.75 0.232 0.213 
4ZB9 22 98 % 2.40 0.273 0.216 
4ECI 23 95 % 1.80 0.209 0.175 
5F05-A 19 96 % 1.70 0.181 0.144 
4Q5F 21 93 % 2.45 0.239 0.188 
5HFK-A 26 97 % 1.55 0.212 0.185 
1DUG-A 30 93 % 1.80 0.226 0.185 




C. parvum GST2 (CpGST2) hits 
 PDB-Chain % Identity Query cover Resolution R-Value Free R-Value Work 
NCBI 5H5L-A 26 73 % 2.00 0.238 0.173 
2WS2-A 22 73 % 2.01 0.290 0.236 
2AAW-A 24 88 % 2.40 0.237 0.194 
2ON7-A 27 37 % 2.40 0.280 0.190 
1OKT-A 24 89 % 1.90 0.259 0.222 
3W8S-A 21 92 % 1.90 0.259 0.222 
1TW9-A 20 92 %   1.71 0.232 0.180 
4ZXG-A 24 86 % 1.70 0.229 0.183 
2ON5-A 21 74 % 1.90 0.227 0.178 
3FR3-A 22 86 % 1.90 0.252 0.211 
3FR6-A 24 86% 2.60 0.302 0.216 
4KDU-A 27 29% 1.60 0.200 0.168 
PHYRE 5H5L-A 21 93 % 2.00 0.238 0.173 
 1K3Y-B 21 94 % 1.30 0.207 0.137 
1M0U-B 19 93 % 1.75 0.232 0.213 
3VPT-A 19 93 % 1.90 0.253 0.204 
1GTU-B 19 94 % 2.88 0.245 0.211 
2WB9-A 18 90 % 1.59 0.222 0.175 
3ISO-B 18 96 % 1.90 0.226 0.179 
1B8X-A 17 95 % 2.70 0.310 0.209 
1BG5-A 17 95 % 2.60 0.359 0.193 
4W66-A 17 95 % 2.39 0.238 0.186 
5AN1-A 17 94 % 2.00 0.262 0.214 
i-TASSER 3ISO-A 20 86 % 1.90 0.226 0.179 
2ON5-A 19 83 % 1.90 0.227 0.178 
1TU7-A 21 83 % 1.5 0.181 0.150 
19GS-A 22 84 % 1.9 0.249 0.212 
2ON7 19 83 % 2.4 0.284 0.190 
4Q5N-A 19 88 % 2.5 0.283 0.224 
19GS 22 80 % 1.9 0.249 0.212 
3GTU-B 19 86 % 2.80 0.270 0.225 
5H5L-A 23 79 % 2.00 0.238 0.173 
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4W66-A 18 84 % 2.39 0.238 0.186 
 
C. meleagridis UKMEL1 GST3 (CmGST3) hits 
 PDB-Chain % Identity Query cover Resolution R-Value Free R-Value Work 
NCBI 1HNA-A 19 92 % 1.85 0.226 0.226 
1XW5-A 19 92 % 1.80 0.232 0.206 
2C4J-A 19 92 % 1.35 0.213 0.194 
2DC5-A 19 92 % 1.60 0.202 0.188 
1GSU-A 22 73 % 1.94 0.292 0.210 
4GTU-A 19 92 % 3.30 0.315 0.245 
6KLD-A 52% 8 % 3.58 - - 
6GSX-A 17% 98% 1.91 - 0.52 
PHYRE 1K3Y-B 22 98 % 1.30 0.207 0.137 
1GUM-A 22 97 % 3.00 0.270 0.253 
1UA5-A 21 97 % 2.50 0.221 0.169 
1B8X-A 20 97 % 2.70 0.310 0.209 
2FHE-A 20 98 % 2.30 0.234 0.183 
1BG5-A 20 99 % 2.60 0.359 0.193 
4W66-A 19 97 % 2.60 0.359 0.193 
1C72-A 19 89 % 2.80 0.280 0.190 
1GTU-B 18 98 % 2.68 0.245 0.211 
4Q5Q-A 18 97 % 1.93 0.227 0.180 
i-TASSER 3ISO-A 20 95 % 1.90 0.226 0.179 
4Q5F-A 18 94 % 2.45 0.239 0.188 
2AAW-C 22 94 % 2.40 0.237 0.194 
2ON7 19 93 % 2.40 0.280 0.190 
1ZL9 21 93 % 2.01 0.209 0.151 
1ZL9-A 21 94 % 2.01 0.209 0.151 
4RI6 20 93 % 1.52 0.183 0.151 
1XW6-A 20 94 % 1.90 0.247 0.227 
1GUL-A 28 92 % 2.70 0.260 0.248 
1B8X-A 24 92 % 2.70 0.310 0.209 
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Table S6: Validation of glutathione transferases (GSTs) from Cryptosporidium parvum (CpGST1 and CpGST2) and Cryptosporidium meleagridis GST3 (CmGST3) protein 
models. For comparative analysis templates were also included in the study.  
 3VPQ 5AN1 CpGST1 post 
refinement 
1K3Y 19GS CpGST2 post 
refinement 
1ZL9 CmGST3 post 
refinement 
Verify 91.63% 87.67% 87.98% 88.69% 100% 83.40% 95.17 % 26.29 % 
Errat 95.8974 92.8571 85.6322 97.1831 99 85.9649 97.4874 82.9146 
Procheck 
errors 
1 2 3 2 0 3 0 2 
Procheck 
Warnings 
4 4 2 4 7 2 6 3 
Procheck 
pass 
4 3 3 3 2 3 3 3 













Table S7: Glutathione transferases (GSTs) from Cryptosporidium parvum (CpGST1 and CpGST2) and Cryptosporidium meleagridis GST3 (CmGST3) protein models 
assessment by Ramachandran Plot. For comparative analysis templates were also included in the study. 
 3VPQ 5AN1 CpGST1 post 
refinement 
1K3Y 19GS CpGST2 post 
refinement 




165 (92.7%) 176 (90.7%) 155 (92.3%) 182 (92.4%) 167 (93.3%) 199 (90.9%) 167 (93%) 185 (92%) 
Additionally 
allowed region 
11 (6.2%) 16 (8.2%) 11 (6.5%) 14 (7.1%) 10 (5.6%) 17 (7.8%) 11 (6.1%) 14 (7%) 
Generously 
allowed region 
4 (1.1%) 2 (1%) 2 (1.2) 1 (0.5%) 2 (1.1%) 3 (1.4 %) 1 (0.6%) 0 
Disallowed 
region 








FASTA SEQUENCES OF GST FROM DIFFERENT CLASSES FOR PHYLOGENETIC TREE 
Cryptosporidium species GSTs 







































































































































































































































































































































































Beta Class GSTs 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CHAPTER 3 SUPPLEMENTARY DATASET 
         
Figure S2: Standard curves relating the relative mobility of the DNA ladder size on 0,75 % agarose gels 
respective to their log base pair sizes to determine the restriction digested fragment sizes. A: The standard 
curve for the pET11a-CpGST and pCOLD1-CpGST restriction digest samples with the GeneRuler 1 Kb DNA Ladder 
(ThermoFisher Scientific , USA). B: The standard curve for the pCOLDTF-CpGST restriction digest samples with 
the 1 Kb DNA Ladder (New England Biolabs, USA).  
 
     
Figure S3: Standard curves relating the relative mobility of the DNA ladder size on 1 % agarose gels respective 
to their log base pair sizes to determine the PCR product sizes. A: The standard curve for the pCOLD1-CpGST 
PCR product samples. B: The standard curve for the pCOLDTF-CpGST PCR product samples. Both samples had 
the FastRuler middle range DNA Ladder (ThermoFisher Scientific , USA).  
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Figure S4: Standard curve relating the relative mobility of the molecular weight marker proteins on 12.5 % 
SDS-PAGE laemmli system respective to their log molecular weight. A: The standard curve for the pCOLD1-
CpGST expression samples with the blue prestained protein standard (New England Biolabs, USA). B: The 
standard curve for the pCOLDTF-CpGST expression samples with the BLUeye prestained ladder (Sigma-Aldrich, 
USA). 
                                     
Figure S5: Standard curve relating the relative mobility of the molecular weight marker proteins on 12.5 % 
SDS-PAGE Laemmli system respective to their log molecular weight. The calibration curve was constructed by 
plotting the Log (Mr) of the protein ladder against the relative mobility of that the proteins travelled. A: The 
standard curve for the pCOLDTF-CpGST expression and eluents after purification. The IMAC and SEC gels were 
run against the PageRuler™ prestained protein ladder (ThermoFisher Scientific, USA)  
 


















Figure S6: pCOLDTF vector map showing the primer recognition sequences. 
 
 
